PapiChulo88的个人主页 - 老虎社区

PapiChulo88

PapiChulo88

暂无个人介绍

IP属地：未知

12关注

4粉丝

0主题

0勋章

2021-06-12

Amazing

抱歉，原内容已删除

2021-07-14

Is it time to buy?

Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.

2021-06-15

Do you agree? Leave a comment

抱歉，原内容已删除

2021-10-23

At the current price of $100 is it still good to enter? $Digital World Acquisition Corp(DWAC)$

2021-06-10

Good read

Goldman Explains Why The Economy Won't Overheat, No Matter What Today's CPI Shows

2021-10-27

It’s a good time to buy

Trump stocks fell sharply in premarket trading

2021-12-17

😭

抱歉，原内容已删除

2021-10-25

Climb

抱歉，原内容已删除

2021-06-09

Is it worth a buy?

Zhangmen Education opens for trading at $17.74, up about 54% from IPO price

2021-11-01

$Naked Brand(NAKD)$What’s happening

2021-10-27

$Digital World Acquisition Corp(DWAC)$Time to enter while at low!

2021-10-23

$Phunware, Inc.(PHUN)$how much will it close tonight?

2021-10-22

I should have bought

抱歉，原内容已删除

2021-06-08

Wow

The Big Changes Coming to Your iPhone, iPad and Mac This Fall

2021-12-17

Wow

抱歉，原内容已删除

2021-06-30

Got me thinking

抱歉，原内容已删除

2021-06-19

Hold clover stocks!

3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%

2021-06-08

Hopefully it will sustain in the Long run

Why Bionano Genomics Stock Soared on Monday

2021-12-17

Oh my

BKKT Stock Alert: Why Is Bakkt Plunging

2021-11-05

Oh my

Bionano Genomics stock tanked more than 8% in premarket trading

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3576458191145383","uuid":"3576458191145383","gmtCreate":1613364167181,"gmtModify":1623129571224,"name":"PapiChulo88","pinyin":"papichulo88","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":12,"tweetSize":36,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":690797621,"gmtCreate":1639707049357,"gmtModify":1639708339012,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Oh my&nbsp;","listText":"Oh my&nbsp;","text":"Oh my","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690797621","repostId":"1155708308","repostType":2,"repost":{"id":"1155708308","kind":"news","pubTimestamp":1639706709,"share":"https://www.laohu8.com/m/news/1155708308?lang=&edition=full","pubTime":"2021-12-17 10:05","market":"us","language":"en","title":"BKKT Stock Alert: Why Is Bakkt Plunging","url":"https://stock-news.laohu8.com/highlight/detail?id=1155708308","media":"InvestorPlace","summary":"Digital asset manager Bakkt(NYSE:BKKT) is in freefall on Thursday after a recent Securities and Exch","content":"<p>Digital asset manager&nbsp;<b>Bakkt</b>(NYSE:<b><u>BKKT</u></b>) is in freefall&nbsp;on&nbsp;Thursday&nbsp;after a recent Securities and Exchange Commission (SEC) filing has investors spooked. BKKT stock is down big today, just two months after its October SPAC debut.</p>\n<p>So, what’s causing this slump in Bakkt?</p>\n<p>Bakkt is falling victim to an apparent PIPE (private investment in public equity) selloff. Yesterday, Bakkt filed an S-1 registration statement with the SEC,&nbsp;allowing early investors&nbsp;in the company freedom to sell their stake. Consequently, they did. Bakkt has already shed more than 31% of its share price as investors cool off on the once red-hot stock.</p>\n<p>Founded in 2018, Bakkt went public just this past October. A week after its debut, BKKT went as high as $42.52 per share amid sky-high investor interest. However, it seems the party is over. Accounting for today’s losses so far, Bakkt is trending a bit below $10 at the time of writing.</p>\n<p>What else do you need to know about Bakkt’s dive?</p>\n<p><b>BKKT Stock Flounders as Bears Come Out on Top</b></p>\n<p>While the PIPE unlocking is wreaking havoc on shareholder wallets, Bakkt is grasping at straws to put a stop to the decline.</p>\n<p>The Georgia-based company is best known for its digital asset exchange platform. Bakkt is the latest crypto exchange making waves after its app launched under the guidance of parent company Intercontinental Exchange.</p>\n<p>Unfortunately, since its Oct. 25 peak, it’s been a downhill story for the crypto exchange. Even despite a headline-grabbing&nbsp;integration announcement&nbsp;with&nbsp;<b>Alphabet’s</b>&nbsp;Google Pay, Bakkt can’t seem to reverse its fortune.</p>\n<p>Additionally, just this week Bakkt began offering&nbsp;<b>WyndhamRewards</b>&nbsp;members the ability to convert reward points into cash deposited directly into their accounts. Unfortunately, it was seemingly to no avail.</p>\n<p>Time will tell just how far BKKT will drop. However, for those looking for cheap crypto exposure, a rock-bottom entry point like this could be appealing.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BKKT Stock Alert: Why Is Bakkt Plunging</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBKKT Stock Alert: Why Is Bakkt Plunging\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 10:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/bkkt-stock-alert-why-is-bakkt-plunging-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Digital asset manager Bakkt(NYSE:BKKT) is in freefall on Thursday after a recent Securities and Exchange Commission (SEC) filing has investors spooked. BKKT stock is down big today, just two months ...</p>\n\n<a href=\"https://investorplace.com/2021/12/bkkt-stock-alert-why-is-bakkt-plunging-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BKKT":"Bakkt Holdings, Inc."},"source_url":"https://investorplace.com/2021/12/bkkt-stock-alert-why-is-bakkt-plunging-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155708308","content_text":"Digital asset manager Bakkt(NYSE:BKKT) is in freefall on Thursday after a recent Securities and Exchange Commission (SEC) filing has investors spooked. BKKT stock is down big today, just two months after its October SPAC debut.\nSo, what’s causing this slump in Bakkt?\nBakkt is falling victim to an apparent PIPE (private investment in public equity) selloff. Yesterday, Bakkt filed an S-1 registration statement with the SEC, allowing early investors in the company freedom to sell their stake. Consequently, they did. Bakkt has already shed more than 31% of its share price as investors cool off on the once red-hot stock.\nFounded in 2018, Bakkt went public just this past October. A week after its debut, BKKT went as high as $42.52 per share amid sky-high investor interest. However, it seems the party is over. Accounting for today’s losses so far, Bakkt is trending a bit below $10 at the time of writing.\nWhat else do you need to know about Bakkt’s dive?\nBKKT Stock Flounders as Bears Come Out on Top\nWhile the PIPE unlocking is wreaking havoc on shareholder wallets, Bakkt is grasping at straws to put a stop to the decline.\nThe Georgia-based company is best known for its digital asset exchange platform. Bakkt is the latest crypto exchange making waves after its app launched under the guidance of parent company Intercontinental Exchange.\nUnfortunately, since its Oct. 25 peak, it’s been a downhill story for the crypto exchange. Even despite a headline-grabbing integration announcement with Alphabet’s Google Pay, Bakkt can’t seem to reverse its fortune.\nAdditionally, just this week Bakkt began offering WyndhamRewards members the ability to convert reward points into cash deposited directly into their accounts. Unfortunately, it was seemingly to no avail.\nTime will tell just how far BKKT will drop. However, for those looking for cheap crypto exposure, a rock-bottom entry point like this could be appealing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690704308,"gmtCreate":1639706305167,"gmtModify":1639706953509,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690704308","repostId":"1172405131","repostType":4,"isVote":1,"tweetType":1,"viewCount":1373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690705530,"gmtCreate":1639706274621,"gmtModify":1639706274754,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690705530","repostId":"604088904","repostType":1,"repost":{"id":604088904,"gmtCreate":1639281345798,"gmtModify":1639358988582,"author":{"id":"3494378197296027","authorId":"3494378197296027","name":"王春龙Bale","avatar":"https://static.tigerbbs.com/11e561afcd6e41b0d7953fc87b7c54a9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3494378197296027","authorIdStr":"3494378197296027"},"themes":[],"htmlText":"今年前三季度国内外手机销量成绩单：三星全球第一，OV中国霸榜，小米在国内力压苹果1、来自调研机构Canalys的最新数据显示，2021年前三季度，全球手机销量中，三星再次占据第一位，三季度出货量6940万台（累计卖出2.039亿台），占21%市场份额；苹果伴随着iPhone13销量提升，以4920万台出货量（累计卖出1.473亿台），排名第二；小米的出货量4400万台排在第三位（累计卖出1.45亿台），达到14%市场份额；OPPO和vivo排在第四和第五位，出货量分别为3670万台和3420万台。2.在中国市场，vivo和OPPO的销量占据前两位，前三季度的销量分别是5810万台和5310万台，小米力压苹果，在中国市场排名第三位，销量为3700万台。苹果和荣耀分别以2820万台和2110万台的三季度总销量，排名第四和第五位。3.关于销量的提升，Canalys首席分析师Ben Stanton表示：“安卓手机的情况不那么乐观，出货量下降了9%。但供应商的命运喜忧参半。三星的Galaxy A系列设备再次供不应求。小米也看到了供不应求的局面，但部分原因是上一季度表现抢眼，耗尽了可用库存。相比之下，上一季度OPPO和vivo在第三季度因新冠病毒肆虐南亚核心市场而反弹。4.但在全球前五位中，三星和小米的销量呈现下降趋势，尤其是三星下降了14%左右，而在正增长幅度上，OPPO增长了18%，苹果增长了14%，vivo增长了8%。在正增长前五位中，中国手机品牌占据两位。<a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a>","listText":"今年前三季度国内外手机销量成绩单：三星全球第一，OV中国霸榜，小米在国内力压苹果1、来自调研机构Canalys的最新数据显示，2021年前三季度，全球手机销量中，三星再次占据第一位，三季度出货量6940万台（累计卖出2.039亿台），占21%市场份额；苹果伴随着iPhone13销量提升，以4920万台出货量（累计卖出1.473亿台），排名第二；小米的出货量4400万台排在第三位（累计卖出1.45亿台），达到14%市场份额；OPPO和vivo排在第四和第五位，出货量分别为3670万台和3420万台。2.在中国市场，vivo和OPPO的销量占据前两位，前三季度的销量分别是5810万台和5310万台，小米力压苹果，在中国市场排名第三位，销量为3700万台。苹果和荣耀分别以2820万台和2110万台的三季度总销量，排名第四和第五位。3.关于销量的提升，Canalys首席分析师Ben Stanton表示：“安卓手机的情况不那么乐观，出货量下降了9%。但供应商的命运喜忧参半。三星的Galaxy A系列设备再次供不应求。小米也看到了供不应求的局面，但部分原因是上一季度表现抢眼，耗尽了可用库存。相比之下，上一季度OPPO和vivo在第三季度因新冠病毒肆虐南亚核心市场而反弹。4.但在全球前五位中，三星和小米的销量呈现下降趋势，尤其是三星下降了14%左右，而在正增长幅度上，OPPO增长了18%，苹果增长了14%，vivo增长了8%。在正增长前五位中，中国手机品牌占据两位。<a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a>","text":"今年前三季度国内外手机销量成绩单：三星全球第一，OV中国霸榜，小米在国内力压苹果1、来自调研机构Canalys的最新数据显示，2021年前三季度，全球手机销量中，三星再次占据第一位，三季度出货量6940万台（累计卖出2.039亿台），占21%市场份额；苹果伴随着iPhone13销量提升，以4920万台出货量（累计卖出1.473亿台），排名第二；小米的出货量4400万台排在第三位（累计卖出1.45亿台），达到14%市场份额；OPPO和vivo排在第四和第五位，出货量分别为3670万台和3420万台。2.在中国市场，vivo和OPPO的销量占据前两位，前三季度的销量分别是5810万台和5310万台，小米力压苹果，在中国市场排名第三位，销量为3700万台。苹果和荣耀分别以2820万台和2110万台的三季度总销量，排名第四和第五位。3.关于销量的提升，Canalys首席分析师Ben Stanton表示：“安卓手机的情况不那么乐观，出货量下降了9%。但供应商的命运喜忧参半。三星的Galaxy A系列设备再次供不应求。小米也看到了供不应求的局面，但部分原因是上一季度表现抢眼，耗尽了可用库存。相比之下，上一季度OPPO和vivo在第三季度因新冠病毒肆虐南亚核心市场而反弹。4.但在全球前五位中，三星和小米的销量呈现下降趋势，尤其是三星下降了14%左右，而在正增长幅度上，OPPO增长了18%，苹果增长了14%，vivo增长了8%。在正增长前五位中，中国手机品牌占据两位。$小米集团-W(01810)$$苹果(AAPL)$","images":[{"img":"https://static.tigerbbs.com/4c8eac165d2046bc5473d6c25feeb539","width":"1080","height":"1611"},{"img":"https://static.tigerbbs.com/869ac9acb00e1ad37f873af33834623c","width":"1000","height":"705"},{"img":"https://static.tigerbbs.com/64235d5f2b7b09ae46076a8da4715361","width":"1000","height":"643"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604088904","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690701170,"gmtCreate":1639706008518,"gmtModify":1639706008640,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"🥺","listText":"🥺","text":"🥺","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690701170","repostId":"607460968","repostType":1,"repost":{"id":607460968,"gmtCreate":1639579382045,"gmtModify":1639704589453,"author":{"id":"3559804133107604","authorId":"3559804133107604","name":"名字就是这样","avatar":"https://static.tigerbbs.com/ecd5018dcfd0f98e2db33cd5b25c541c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3559804133107604","authorIdStr":"3559804133107604"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNGO\">$Bionano Genomics(BNGO)$</a>买定离手[可爱]&nbsp;[可爱]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BNGO\">$Bionano Genomics(BNGO)$</a>买定离手[可爱]&nbsp;[可爱]&nbsp;","text":"$Bionano Genomics(BNGO)$买定离手[可爱] [可爱]","images":[{"img":"https://static.tigerbbs.com/46343c9bd8b490ff7fcdbb048c54a4e2","width":"750","height":"1334"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607460968","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690703919,"gmtCreate":1639705922440,"gmtModify":1639705922561,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"😭","listText":"😭","text":"😭","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690703919","repostId":"2192920942","repostType":4,"isVote":1,"tweetType":1,"viewCount":1151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844822526,"gmtCreate":1636417891085,"gmtModify":1636417891215,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>is&nbsp;up!&nbsp;","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>is&nbsp;up!&nbsp;","text":"$Naked Brand(NAKD)$is up!","images":[{"img":"https://static.tigerbbs.com/5082d8e62ecba911cc847ce3b96ab592","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844822526","isVote":1,"tweetType":1,"viewCount":1540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846430950,"gmtCreate":1636102914954,"gmtModify":1636102915010,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Oh my&nbsp;","listText":"Oh my&nbsp;","text":"Oh my","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846430950","repostId":"1194946622","repostType":4,"repost":{"id":"1194946622","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636101187,"share":"https://www.laohu8.com/m/news/1194946622?lang=&edition=full","pubTime":"2021-11-05 16:33","market":"us","language":"en","title":"Bionano Genomics stock tanked more than 8% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1194946622","media":"Tiger Newspress","summary":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $","content":"<p>Bionano Genomics stock tanked more than 8% in premarket trading&nbsp;after&nbsp;Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p>\n<p><img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p><b>Bionano Genomics, Inc.</b>&nbsp;reported financial results and business achievements for the quarter ended&nbsp;September&nbsp;30, 2021&nbsp;and highlighted recent corporate updates.</p>\n<p><i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p>\n<p><i>–&nbsp;Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p>\n<p><i>–&nbsp;Record number of Saphyr shipments and installations for any quarter to date</i></p>\n<p><i>–&nbsp;Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p>\n<p><i>–&nbsp;Remaining 2021 milestones on track</i></p>\n<p><i>–&nbsp;Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember&nbsp;30, 2021</i></p>\n<p>“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p>\n<p>Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p>\n<p><b>Key Business Highlights in Q3</b></p>\n<p>The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p>\n<p>–<b>&nbsp;Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p>\n<p>–<b>&nbsp;Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p>\n<p>–<b>&nbsp;Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p>\n<p>–&nbsp;<b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham &amp; Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p>\n<p>–<b>&nbsp;The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p>\n<p>–<b>&nbsp;NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p>\n<p>–<b>&nbsp;Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p>\n<p>–&nbsp;<b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p>\n<p>–&nbsp;<b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p>\n<p><b>Financial Highlights</b></p>\n<p>–<b>&nbsp;Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p>\n<p>–<b>&nbsp;Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p>\n<p>–<b>&nbsp;Third quarter operating expense was$21.8 million,</b>compared to$17.9&nbsp;million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p>\n<p>–&nbsp;<b>AtSeptember&nbsp;30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p>\n<p><b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p>\n<p>–&nbsp;4Q21: Interim publication of results from pediatric clinical study</p>\n<p>–&nbsp;4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p>\n<p>–&nbsp;4Q21: Initial prototype of next gen high throughput Saphyr</p>\n<p>–&nbsp;4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics stock tanked more than 8% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics stock tanked more than 8% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-05 16:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bionano Genomics stock tanked more than 8% in premarket trading&nbsp;after&nbsp;Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p>\n<p><img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p><b>Bionano Genomics, Inc.</b>&nbsp;reported financial results and business achievements for the quarter ended&nbsp;September&nbsp;30, 2021&nbsp;and highlighted recent corporate updates.</p>\n<p><i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p>\n<p><i>–&nbsp;Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p>\n<p><i>–&nbsp;Record number of Saphyr shipments and installations for any quarter to date</i></p>\n<p><i>–&nbsp;Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p>\n<p><i>–&nbsp;Remaining 2021 milestones on track</i></p>\n<p><i>–&nbsp;Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember&nbsp;30, 2021</i></p>\n<p>“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p>\n<p>Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p>\n<p><b>Key Business Highlights in Q3</b></p>\n<p>The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p>\n<p>–<b>&nbsp;Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p>\n<p>–<b>&nbsp;Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p>\n<p>–<b>&nbsp;Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p>\n<p>–&nbsp;<b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham &amp; Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p>\n<p>–<b>&nbsp;The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p>\n<p>–<b>&nbsp;NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p>\n<p>–<b>&nbsp;Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p>\n<p>–&nbsp;<b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p>\n<p>–&nbsp;<b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p>\n<p><b>Financial Highlights</b></p>\n<p>–<b>&nbsp;Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p>\n<p>–<b>&nbsp;Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p>\n<p>–<b>&nbsp;Third quarter operating expense was$21.8 million,</b>compared to$17.9&nbsp;million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p>\n<p>–&nbsp;<b>AtSeptember&nbsp;30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p>\n<p><b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p>\n<p>–&nbsp;4Q21: Interim publication of results from pediatric clinical study</p>\n<p>–&nbsp;4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p>\n<p>–&nbsp;4Q21: Initial prototype of next gen high throughput Saphyr</p>\n<p>–&nbsp;4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194946622","content_text":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.\n\nBionano Genomics, Inc. reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.\n– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics\n– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base\n– Record number of Saphyr shipments and installations for any quarter to date\n– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications\n– Remaining 2021 milestones on track\n– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021\n“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.\nChris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”\nKey Business Highlights in Q3\nThe Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:\n– Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.\n– Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.\n– Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applicationssupporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.\n– OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centersinthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.\n– The largest clinical research study to date evaluating OGM was published inThe Journal of Molecular Diagnosticsfor a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.\n– NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.\n– Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.\n– Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.\n– Added exceptional talent across commercial leadership functions,includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.\nFinancial Highlights\n– Total revenue for the third quarter of 2021 was$4.7 million,up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.\n– Gross margin for the third quarter of 2021 was 24.8%,compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.\n– Third quarter operating expense was$21.8 million,compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.\n– AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 millioncompared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.\nRemaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr\n– 4Q21: Interim publication of results from pediatric clinical study\n– 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study\n– 4Q21: Initial prototype of next gen high throughput Saphyr\n– 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020","news_type":1},"isVote":1,"tweetType":1,"viewCount":1250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849793486,"gmtCreate":1635776244013,"gmtModify":1635776244116,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HCWB\">$HCW Biologics Inc.(HCWB)$</a>Hold! It will be up again","listText":"<a href=\"https://laohu8.com/S/HCWB\">$HCW Biologics Inc.(HCWB)$</a>Hold! It will be up again","text":"$HCW Biologics Inc.(HCWB)$Hold! It will be up again","images":[{"img":"https://static.tigerbbs.com/9f78f1e45b52a24e3b5ad8e881f3d849","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849793486","isVote":1,"tweetType":1,"viewCount":1542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":849799713,"gmtCreate":1635776203533,"gmtModify":1635776203533,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>What’s happening&nbsp;","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>What’s happening&nbsp;","text":"$Naked Brand(NAKD)$What’s happening","images":[{"img":"https://static.tigerbbs.com/a9221a997ccd4e8a44354ac7a05795c6","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849799713","isVote":1,"tweetType":1,"viewCount":1223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":855989602,"gmtCreate":1635324421107,"gmtModify":1635324421107,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"It’s a good time to buy&nbsp;","listText":"It’s a good time to buy&nbsp;","text":"It’s a good time to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855989602","repostId":"1105918886","repostType":4,"repost":{"id":"1105918886","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635322218,"share":"https://www.laohu8.com/m/news/1105918886?lang=&edition=full","pubTime":"2021-10-27 16:10","market":"us","language":"en","title":"Trump stocks fell sharply in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1105918886","media":"Tiger Newspress","summary":"Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%","content":"<p>Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%.<img src=\"https://static.tigerbbs.com/a94b366462004373a3f94a989d88dc52\" tg-width=\"285\" tg-height=\"124\" referrerpolicy=\"no-referrer\">Donald Trump has dropped from the Forbes 400 list of the richest Americans for the first time in 25 years, according to the Forbes list. Although Trump's current value of $2.5 billion is still worthy of being called \"super rich\", he is still $400 million short of the Forbes 400 Rich List in the past.</p>\n<p>Last week,Trump announced plans to set up his new social platform \"TRUTH Social\" and go public through SPAC company DWAC.&nbsp;While&nbsp;Phunware's software previously provided mobile applications for Trump campaign team.And recently,Creatd&nbsp;announced a new non-fungible token art drop through its OG Gallery unit consisting of three photographs of Trump. The NFT includes three candid images of a young Donald Trump, captured as he signs the breast of a model.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trump stocks fell sharply in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrump stocks fell sharply in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-27 16:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%.<img src=\"https://static.tigerbbs.com/a94b366462004373a3f94a989d88dc52\" tg-width=\"285\" tg-height=\"124\" referrerpolicy=\"no-referrer\">Donald Trump has dropped from the Forbes 400 list of the richest Americans for the first time in 25 years, according to the Forbes list. Although Trump's current value of $2.5 billion is still worthy of being called \"super rich\", he is still $400 million short of the Forbes 400 Rich List in the past.</p>\n<p>Last week,Trump announced plans to set up his new social platform \"TRUTH Social\" and go public through SPAC company DWAC.&nbsp;While&nbsp;Phunware's software previously provided mobile applications for Trump campaign team.And recently,Creatd&nbsp;announced a new non-fungible token art drop through its OG Gallery unit consisting of three photographs of Trump. The NFT includes three candid images of a young Donald Trump, captured as he signs the breast of a model.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRTD":"Creatd Inc","PHUN":"Phunware, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105918886","content_text":"Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%.Donald Trump has dropped from the Forbes 400 list of the richest Americans for the first time in 25 years, according to the Forbes list. Although Trump's current value of $2.5 billion is still worthy of being called \"super rich\", he is still $400 million short of the Forbes 400 Rich List in the past.\nLast week,Trump announced plans to set up his new social platform \"TRUTH Social\" and go public through SPAC company DWAC. While Phunware's software previously provided mobile applications for Trump campaign team.And recently,Creatd announced a new non-fungible token art drop through its OG Gallery unit consisting of three photographs of Trump. The NFT includes three candid images of a young Donald Trump, captured as he signs the breast of a model.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1023,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852236859,"gmtCreate":1635270147306,"gmtModify":1635270147484,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>Time to enter while at low!&nbsp;","listText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>Time to enter while at low!&nbsp;","text":"$Digital World Acquisition Corp(DWAC)$Time to enter while at low!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852236859","isVote":1,"tweetType":1,"viewCount":411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856999794,"gmtCreate":1635137360263,"gmtModify":1635137360978,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Climb&nbsp;","listText":"Climb&nbsp;","text":"Climb","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856999794","repostId":"1163651002","repostType":4,"isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851411293,"gmtCreate":1634920284934,"gmtModify":1634920285058,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"At the current price of $100 is it still good to enter?&nbsp;<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>","listText":"At the current price of $100 is it still good to enter?&nbsp;<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>","text":"At the current price of $100 is it still good to enter? $Digital World Acquisition Corp(DWAC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/851411293","isVote":1,"tweetType":1,"viewCount":2546,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851413255,"gmtCreate":1634920191805,"gmtModify":1634920191971,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>how much will it close tonight?","listText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>how much will it close tonight?","text":"$Phunware, Inc.(PHUN)$how much will it close tonight?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851413255","isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851165572,"gmtCreate":1634882913211,"gmtModify":1634882913259,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"I should have bought&nbsp;","listText":"I should have bought&nbsp;","text":"I should have bought","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851165572","repostId":"1189311420","repostType":2,"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":893241287,"gmtCreate":1628267514049,"gmtModify":1631890836755,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"So which is which?","listText":"So which is which?","text":"So which is which?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893241287","repostId":"2157935944","repostType":2,"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808887870,"gmtCreate":1627569070890,"gmtModify":1631890836771,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>continue to rise please&nbsp;","listText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>continue to rise please&nbsp;","text":"$NIO Inc.(NIO)$continue to rise please","images":[{"img":"https://static.tigerbbs.com/c06925d7304821df7cce9fd43d2e4c53","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808887870","isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":144909061,"gmtCreate":1626257904753,"gmtModify":1631890836783,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Is it time to buy?","listText":"Is it time to buy?","text":"Is it time to buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/144909061","repostId":"1165083410","repostType":4,"repost":{"id":"1165083410","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626256074,"share":"https://www.laohu8.com/m/news/1165083410?lang=&edition=full","pubTime":"2021-07-14 17:47","market":"us","language":"en","title":"Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.","url":"https://stock-news.laohu8.com/highlight/detail?id=1165083410","media":"Tiger Newspress","summary":"Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of ","content":"<p>Cannabis&nbsp;stocks&nbsp;gains&nbsp;in premarket&nbsp;trading,as&nbsp;senators unveiling plan to end federal prohibition of cannabis.</p>\n<p>SNDL&nbsp;shares&nbsp;rises&nbsp;4%&nbsp;in&nbsp;premarket,&nbsp;TLRY&nbsp;and&nbsp;ACB&nbsp;shares&nbsp;are&nbsp;up&nbsp;2%.</p>\n<p><img src=\"https://static.tigerbbs.com/231cd44d5edcf10717dd42ede4ccbed1\" tg-width=\"1289\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>Senate Majority Leader Chuck Schumer (D., N.Y.), Sen. Ron Wyden (D., Oreg.) and Sen. Cory Booker (D., N.J.) are unveiling a discussion draft of their legislation to end the federal prohibition of marijuana. The senators will detail their plan at a press conference on July 14.</p>\n<p>The proposal— known as the Cannabis Administration and Opportunity Act — calls for removing cannabis from the federal list of controlled substances, allowing states to make their own decisions on cannabis. Many states have already moved to legalize recreational or medicinal marijuana use, but it still remains illegal under federal law.</p>\n<p>\"By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal,\" reads the discussion draft. \"State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled.\"</p>\n<p>The proposal establishes 21 as the minimum age to purchase cannabis and limits retail sales to no more than 10 ounces of cannabis. It calls for federal agencies to research the impacts of cannabis use, legalization and cannabis-impaired driving — including research to establish an impairment standard for driving under the influence of cannabis.</p>\n<p>The Democratic trio has been working on the legislation for months. In an interview withYahoo Financeshortly after they announced their plan to work on the proposal, Sen. Wyden said Congress should \"finally recognize that the War on Drugs has failed.\"</p>\n<p>The plan would require expungement of federal non-violent cannabis convictions and encourage state and local governments to do the same. It would keep people from being denied federal benefits — such as housing or federal financial aid — because of cannabis use or possession. People who are not U.S. citizens could not be denied benefits or protection under immigration laws.</p>\n<p>The plan would also create new grant programs to fund nonprofits that help people who have been \"adversely impacted by the War on Drugs.\" It would make loans available to small businesses in the cannabis industry and help states and localities implement cannabis licensing programs.</p>\n<p>President Joe Biden backed decriminalization of marijuana on the campaign trail, but the White House has not backed legalization efforts. In December, the Housepassed the MORE Act— which would remove marijuana from the controlled substance list and create restorative justice programs. Earlier this year, Rep. Jerry Nadler (D., N.Y.)reintroducedthe legislation.</p>\n<p>The senators are asking for input on the proposal by Sept. 1, so they can consider feedback before crafting the final bill. The proposal faces a difficult vote in the evenly-divided Senate.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-14 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cannabis&nbsp;stocks&nbsp;gains&nbsp;in premarket&nbsp;trading,as&nbsp;senators unveiling plan to end federal prohibition of cannabis.</p>\n<p>SNDL&nbsp;shares&nbsp;rises&nbsp;4%&nbsp;in&nbsp;premarket,&nbsp;TLRY&nbsp;and&nbsp;ACB&nbsp;shares&nbsp;are&nbsp;up&nbsp;2%.</p>\n<p><img src=\"https://static.tigerbbs.com/231cd44d5edcf10717dd42ede4ccbed1\" tg-width=\"1289\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>Senate Majority Leader Chuck Schumer (D., N.Y.), Sen. Ron Wyden (D., Oreg.) and Sen. Cory Booker (D., N.J.) are unveiling a discussion draft of their legislation to end the federal prohibition of marijuana. The senators will detail their plan at a press conference on July 14.</p>\n<p>The proposal— known as the Cannabis Administration and Opportunity Act — calls for removing cannabis from the federal list of controlled substances, allowing states to make their own decisions on cannabis. Many states have already moved to legalize recreational or medicinal marijuana use, but it still remains illegal under federal law.</p>\n<p>\"By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal,\" reads the discussion draft. \"State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled.\"</p>\n<p>The proposal establishes 21 as the minimum age to purchase cannabis and limits retail sales to no more than 10 ounces of cannabis. It calls for federal agencies to research the impacts of cannabis use, legalization and cannabis-impaired driving — including research to establish an impairment standard for driving under the influence of cannabis.</p>\n<p>The Democratic trio has been working on the legislation for months. In an interview withYahoo Financeshortly after they announced their plan to work on the proposal, Sen. Wyden said Congress should \"finally recognize that the War on Drugs has failed.\"</p>\n<p>The plan would require expungement of federal non-violent cannabis convictions and encourage state and local governments to do the same. It would keep people from being denied federal benefits — such as housing or federal financial aid — because of cannabis use or possession. People who are not U.S. citizens could not be denied benefits or protection under immigration laws.</p>\n<p>The plan would also create new grant programs to fund nonprofits that help people who have been \"adversely impacted by the War on Drugs.\" It would make loans available to small businesses in the cannabis industry and help states and localities implement cannabis licensing programs.</p>\n<p>President Joe Biden backed decriminalization of marijuana on the campaign trail, but the White House has not backed legalization efforts. In December, the Housepassed the MORE Act— which would remove marijuana from the controlled substance list and create restorative justice programs. Earlier this year, Rep. Jerry Nadler (D., N.Y.)reintroducedthe legislation.</p>\n<p>The senators are asking for input on the proposal by Sept. 1, so they can consider feedback before crafting the final bill. The proposal faces a difficult vote in the evenly-divided Senate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc.","SNDL":"SNDL Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165083410","content_text":"Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.\nSNDL shares rises 4% in premarket, TLRY and ACB shares are up 2%.\n\nSenate Majority Leader Chuck Schumer (D., N.Y.), Sen. Ron Wyden (D., Oreg.) and Sen. Cory Booker (D., N.J.) are unveiling a discussion draft of their legislation to end the federal prohibition of marijuana. The senators will detail their plan at a press conference on July 14.\nThe proposal— known as the Cannabis Administration and Opportunity Act — calls for removing cannabis from the federal list of controlled substances, allowing states to make their own decisions on cannabis. Many states have already moved to legalize recreational or medicinal marijuana use, but it still remains illegal under federal law.\n\"By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal,\" reads the discussion draft. \"State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled.\"\nThe proposal establishes 21 as the minimum age to purchase cannabis and limits retail sales to no more than 10 ounces of cannabis. It calls for federal agencies to research the impacts of cannabis use, legalization and cannabis-impaired driving — including research to establish an impairment standard for driving under the influence of cannabis.\nThe Democratic trio has been working on the legislation for months. In an interview withYahoo Financeshortly after they announced their plan to work on the proposal, Sen. Wyden said Congress should \"finally recognize that the War on Drugs has failed.\"\nThe plan would require expungement of federal non-violent cannabis convictions and encourage state and local governments to do the same. It would keep people from being denied federal benefits — such as housing or federal financial aid — because of cannabis use or possession. People who are not U.S. citizens could not be denied benefits or protection under immigration laws.\nThe plan would also create new grant programs to fund nonprofits that help people who have been \"adversely impacted by the War on Drugs.\" It would make loans available to small businesses in the cannabis industry and help states and localities implement cannabis licensing programs.\nPresident Joe Biden backed decriminalization of marijuana on the campaign trail, but the White House has not backed legalization efforts. In December, the Housepassed the MORE Act— which would remove marijuana from the controlled substance list and create restorative justice programs. Earlier this year, Rep. Jerry Nadler (D., N.Y.)reintroducedthe legislation.\nThe senators are asking for input on the proposal by Sept. 1, so they can consider feedback before crafting the final bill. The proposal faces a difficult vote in the evenly-divided Senate.","news_type":1},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152687989,"gmtCreate":1625288278341,"gmtModify":1631890836796,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Hmmmm…","listText":"Hmmmm…","text":"Hmmmm…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/152687989","repostId":"1188153141","repostType":4,"repost":{"id":"1188153141","kind":"news","pubTimestamp":1625276221,"share":"https://www.laohu8.com/m/news/1188153141?lang=&edition=full","pubTime":"2021-07-03 09:37","market":"us","language":"en","title":"Suze Orman worries about a market crash — here's what you should do","url":"https://stock-news.laohu8.com/highlight/detail?id=1188153141","media":"MoneyWise","summary":"As stock markets continue setting records, fallout from COVID-19 continues to create problems for th","content":"<p>As stock markets continue setting records, fallout from COVID-19 continues to create problems for the economy.</p>\n<p>That clash has worried investing experts, including Suze Orman, who's gone so far as to say she’s now preparing for an inevitable market crash.</p>\n<p>And a famous measurement popularized by Warren Buffett — known as the Buffett Indicator — shows Orman might be onto something.</p>\n<p>Here’s an explanation of where the concern is coming from and some techniques you can use tokeep your investment portfolio growingeven if the market goes south.</p>\n<p><b>What does Suze Orman think?</b></p>\n<p><img src=\"https://static.tigerbbs.com/be8dc3ad363faad96bc575a22235562d\" tg-width=\"703\" tg-height=\"293\" referrerpolicy=\"no-referrer\">Mediapunch/Shutterstock</p>\n<p>Suze Orman has avidly watched the market for decades. She knows ups and downs are to be expected, but what she’s seeing happen with investment fads like GameStop has her concerned.</p>\n<p>“I don’t like what I see happening in the market right now,” Orman said in a video for CNBC. “The economy has been horrible, but the stock market has been going.”</p>\n<p>While investing is as easy now asusing a smartphone app, Orman is concerned about where we can go from these record highs.</p>\n<p>And even with stimulus checks, which are still going out, and the real estate market breaking its own records last year, Orman worries about what will come with the coronavirus — especially as new variants continue to pop up.</p>\n<p>What's more, she feels it’s just been too long since the last crash to stay this high much longer.</p>\n<p>“This reminds me of 2000 all over again,” Orman says.</p>\n<p><b>The Buffett Indicator</b></p>\n<p><img src=\"https://static.tigerbbs.com/44ada32ecadcc4581fed208f4f4e4d53\" tg-width=\"703\" tg-height=\"293\" referrerpolicy=\"no-referrer\">Larry W Smith/EPA/Shutterstock</p>\n<p>One metric Warren Buffett uses to assess the market so regularly that it’s been named after him has been flashing red for long enough that market watchers are starting to wonder if it’s an outdated tool.</p>\n<p>But the Buffett Indicator, a measurement of the ratio of the stock market’s total value against U.S. economic output, continues to climb to previously unseen levels.</p>\n<p>And those in the know are wondering if it's a sign that we’re about to see a hard fall.</p>\n<p>How to prepare for a crash<img src=\"https://static.tigerbbs.com/1ad912a6b4611d9e39b46d2851c78c9e\" tg-width=\"703\" tg-height=\"293\" referrerpolicy=\"no-referrer\">Freedomz / Shutterstock</p>\n<p>Orman has three recommendations for setting up a simple investment strategy to help you successfully navigate any sharp turns in the market.</p>\n<p><b>1. Buy low</b></p>\n<p>Part of what upsets Orman so much about the furor over meme stocks like GameStop is it goes completely against the average investor’s interests.</p>\n<p>“All of you have your heads screwed on backwards,” she says. “All you want is for these markets to go up and up and up. What good is that going to do you?”</p>\n<p>She points out the only extra money most people have goes towardinvesting for retirementin their 401(k) or IRA plans.</p>\n<p>Because you probably don’t plan to touch that money for decades, the best long-term strategy is to buy low. That way, your dollar will go much further now, leaving plenty of room for growth over the next 20, 30 or 40 years.</p>\n<p><b>2. Invest on a schedule</b></p>\n<p><img src=\"https://static.tigerbbs.com/e4102f8a6d5002090743b1cbded32ef9\" tg-width=\"703\" tg-height=\"293\" referrerpolicy=\"no-referrer\">katjen / Shutterstock</p>\n<p>While she prefers to buy low, Orman doesn’t recommend you stop investing completely when the market goes up.</p>\n<p>She wants casual investors to not get caught up in the daily ups and downs of the market.</p>\n<p>In fact, cheering for downturns now may be your best bet at getting a larger piece of very profitable investments — like some lucky investors were able to do back in 2007 and 2008.</p>\n<p>“When the market went down, down, down you could buy things at nothing,” says Orman. “And now look at them 15 years later.”</p>\n<p>She suggests you set up a dollar-cost averaging strategy, which means you invest your money in equal portions at regular intervals, regardless of the market’s fluctuations.</p>\n<p>This kind of approach is easy to implement with any of the many investing apps currently available to DIY investors.</p>\n<p>There are even apps that willautomatically invest your spare changeby rounding up your debit and credit card purchases to the nearest dollar.</p>\n<p><b>3. Diversify with fractional shares</b></p>\n<p>To help weather dips in specific corners of the market, Orman suggests you diversify your investments — balance your portfolio with investments in many different types of assets and sectors of the economy.</p>\n<p>Orman particularly recommends fractional-share investing. This approach allows you to buy a slice of a share for a big-name company that you otherwise wouldn’t be able to afford.</p>\n<p>With the help of apopular stock-trading tool, anyone at any budget can afford the fractional share strategy.</p>\n<p>“The sooner you begin, the more money you will have,” says Orman. “Just don’t stop, and when these markets go down, you should be so happy because your dollars find more shares.”</p>\n<p>“And the more shares you have, the more money you’ll have 20, 40, 50 years from now.”</p>\n<p><b>What else you can do</b></p>\n<p><img src=\"https://static.tigerbbs.com/5e79c6fd1f8fa6e3a7c3a6c94f1e14b5\" tg-width=\"703\" tg-height=\"293\" referrerpolicy=\"no-referrer\">goodluz / Shutterstock</p>\n<p>Whether or not a big crash is around the corner, investors who are still decades out from retirement can make that work for them, Orman said in theCNBC video.</p>\n<p>First, prepare for the worst and hope for the best. Since the onset of the pandemic, Orman now recommends everyone have an emergency fund that can cover their expenses for a full year.</p>\n<p>Then, to set yourself up fora comfortable retirement, she suggests you opt for a Roth account, whether that’s a 401(k) or IRA.</p>\n<p>That will help you avoid paying tax when you take money out of your retirement account because your contributions to a Roth account are made after tax. Traditional IRAs, on the other hand, aren’t taxed when you make contributions, so you’ll end up paying later.</p>\n<p>If you find you need a little more guidance, working with aprofessional financial adviser, can help point you in the right direction so you can confidently ride out any market volatility.</p>\n<p>While everyone else is veering off course or overcorrecting, you’ll be firmly in the driver’s seat with your sunset years planned for.</p>","source":"lsy1621813427262","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Suze Orman worries about a market crash — here's what you should do</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSuze Orman worries about a market crash — here's what you should do\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-03 09:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/suze-orman-worries-market-crash-220000108.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As stock markets continue setting records, fallout from COVID-19 continues to create problems for the economy.\nThat clash has worried investing experts, including Suze Orman, who's gone so far as to ...</p>\n\n<a href=\"https://finance.yahoo.com/news/suze-orman-worries-market-crash-220000108.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/suze-orman-worries-market-crash-220000108.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188153141","content_text":"As stock markets continue setting records, fallout from COVID-19 continues to create problems for the economy.\nThat clash has worried investing experts, including Suze Orman, who's gone so far as to say she’s now preparing for an inevitable market crash.\nAnd a famous measurement popularized by Warren Buffett — known as the Buffett Indicator — shows Orman might be onto something.\nHere’s an explanation of where the concern is coming from and some techniques you can use tokeep your investment portfolio growingeven if the market goes south.\nWhat does Suze Orman think?\nMediapunch/Shutterstock\nSuze Orman has avidly watched the market for decades. She knows ups and downs are to be expected, but what she’s seeing happen with investment fads like GameStop has her concerned.\n“I don’t like what I see happening in the market right now,” Orman said in a video for CNBC. “The economy has been horrible, but the stock market has been going.”\nWhile investing is as easy now asusing a smartphone app, Orman is concerned about where we can go from these record highs.\nAnd even with stimulus checks, which are still going out, and the real estate market breaking its own records last year, Orman worries about what will come with the coronavirus — especially as new variants continue to pop up.\nWhat's more, she feels it’s just been too long since the last crash to stay this high much longer.\n“This reminds me of 2000 all over again,” Orman says.\nThe Buffett Indicator\nLarry W Smith/EPA/Shutterstock\nOne metric Warren Buffett uses to assess the market so regularly that it’s been named after him has been flashing red for long enough that market watchers are starting to wonder if it’s an outdated tool.\nBut the Buffett Indicator, a measurement of the ratio of the stock market’s total value against U.S. economic output, continues to climb to previously unseen levels.\nAnd those in the know are wondering if it's a sign that we’re about to see a hard fall.\nHow to prepare for a crashFreedomz / Shutterstock\nOrman has three recommendations for setting up a simple investment strategy to help you successfully navigate any sharp turns in the market.\n1. Buy low\nPart of what upsets Orman so much about the furor over meme stocks like GameStop is it goes completely against the average investor’s interests.\n“All of you have your heads screwed on backwards,” she says. “All you want is for these markets to go up and up and up. What good is that going to do you?”\nShe points out the only extra money most people have goes towardinvesting for retirementin their 401(k) or IRA plans.\nBecause you probably don’t plan to touch that money for decades, the best long-term strategy is to buy low. That way, your dollar will go much further now, leaving plenty of room for growth over the next 20, 30 or 40 years.\n2. Invest on a schedule\nkatjen / Shutterstock\nWhile she prefers to buy low, Orman doesn’t recommend you stop investing completely when the market goes up.\nShe wants casual investors to not get caught up in the daily ups and downs of the market.\nIn fact, cheering for downturns now may be your best bet at getting a larger piece of very profitable investments — like some lucky investors were able to do back in 2007 and 2008.\n“When the market went down, down, down you could buy things at nothing,” says Orman. “And now look at them 15 years later.”\nShe suggests you set up a dollar-cost averaging strategy, which means you invest your money in equal portions at regular intervals, regardless of the market’s fluctuations.\nThis kind of approach is easy to implement with any of the many investing apps currently available to DIY investors.\nThere are even apps that willautomatically invest your spare changeby rounding up your debit and credit card purchases to the nearest dollar.\n3. Diversify with fractional shares\nTo help weather dips in specific corners of the market, Orman suggests you diversify your investments — balance your portfolio with investments in many different types of assets and sectors of the economy.\nOrman particularly recommends fractional-share investing. This approach allows you to buy a slice of a share for a big-name company that you otherwise wouldn’t be able to afford.\nWith the help of apopular stock-trading tool, anyone at any budget can afford the fractional share strategy.\n“The sooner you begin, the more money you will have,” says Orman. “Just don’t stop, and when these markets go down, you should be so happy because your dollars find more shares.”\n“And the more shares you have, the more money you’ll have 20, 40, 50 years from now.”\nWhat else you can do\ngoodluz / Shutterstock\nWhether or not a big crash is around the corner, investors who are still decades out from retirement can make that work for them, Orman said in theCNBC video.\nFirst, prepare for the worst and hope for the best. Since the onset of the pandemic, Orman now recommends everyone have an emergency fund that can cover their expenses for a full year.\nThen, to set yourself up fora comfortable retirement, she suggests you opt for a Roth account, whether that’s a 401(k) or IRA.\nThat will help you avoid paying tax when you take money out of your retirement account because your contributions to a Roth account are made after tax. Traditional IRAs, on the other hand, aren’t taxed when you make contributions, so you’ll end up paying later.\nIf you find you need a little more guidance, working with aprofessional financial adviser, can help point you in the right direction so you can confidently ride out any market volatility.\nWhile everyone else is veering off course or overcorrecting, you’ll be firmly in the driver’s seat with your sunset years planned for.","news_type":1},"isVote":1,"tweetType":1,"viewCount":253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153240811,"gmtCreate":1625029631033,"gmtModify":1631890836808,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Got me thinking&nbsp;","listText":"Got me thinking&nbsp;","text":"Got me thinking","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/153240811","repostId":"2147585034","repostType":4,"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":186312955,"gmtCreate":1623473296277,"gmtModify":1631890836870,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Amazing","listText":"Amazing","text":"Amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/186312955","repostId":"2142204074","repostType":4,"isVote":1,"tweetType":1,"viewCount":134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":144909061,"gmtCreate":1626257904753,"gmtModify":1631890836783,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Is it time to buy?","listText":"Is it time to buy?","text":"Is it time to buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/144909061","repostId":"1165083410","repostType":4,"repost":{"id":"1165083410","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626256074,"share":"https://www.laohu8.com/m/news/1165083410?lang=&edition=full","pubTime":"2021-07-14 17:47","market":"us","language":"en","title":"Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.","url":"https://stock-news.laohu8.com/highlight/detail?id=1165083410","media":"Tiger Newspress","summary":"Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of ","content":"<p>Cannabis&nbsp;stocks&nbsp;gains&nbsp;in premarket&nbsp;trading,as&nbsp;senators unveiling plan to end federal prohibition of cannabis.</p>\n<p>SNDL&nbsp;shares&nbsp;rises&nbsp;4%&nbsp;in&nbsp;premarket,&nbsp;TLRY&nbsp;and&nbsp;ACB&nbsp;shares&nbsp;are&nbsp;up&nbsp;2%.</p>\n<p><img src=\"https://static.tigerbbs.com/231cd44d5edcf10717dd42ede4ccbed1\" tg-width=\"1289\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>Senate Majority Leader Chuck Schumer (D., N.Y.), Sen. Ron Wyden (D., Oreg.) and Sen. Cory Booker (D., N.J.) are unveiling a discussion draft of their legislation to end the federal prohibition of marijuana. The senators will detail their plan at a press conference on July 14.</p>\n<p>The proposal— known as the Cannabis Administration and Opportunity Act — calls for removing cannabis from the federal list of controlled substances, allowing states to make their own decisions on cannabis. Many states have already moved to legalize recreational or medicinal marijuana use, but it still remains illegal under federal law.</p>\n<p>\"By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal,\" reads the discussion draft. \"State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled.\"</p>\n<p>The proposal establishes 21 as the minimum age to purchase cannabis and limits retail sales to no more than 10 ounces of cannabis. It calls for federal agencies to research the impacts of cannabis use, legalization and cannabis-impaired driving — including research to establish an impairment standard for driving under the influence of cannabis.</p>\n<p>The Democratic trio has been working on the legislation for months. In an interview withYahoo Financeshortly after they announced their plan to work on the proposal, Sen. Wyden said Congress should \"finally recognize that the War on Drugs has failed.\"</p>\n<p>The plan would require expungement of federal non-violent cannabis convictions and encourage state and local governments to do the same. It would keep people from being denied federal benefits — such as housing or federal financial aid — because of cannabis use or possession. People who are not U.S. citizens could not be denied benefits or protection under immigration laws.</p>\n<p>The plan would also create new grant programs to fund nonprofits that help people who have been \"adversely impacted by the War on Drugs.\" It would make loans available to small businesses in the cannabis industry and help states and localities implement cannabis licensing programs.</p>\n<p>President Joe Biden backed decriminalization of marijuana on the campaign trail, but the White House has not backed legalization efforts. In December, the Housepassed the MORE Act— which would remove marijuana from the controlled substance list and create restorative justice programs. Earlier this year, Rep. Jerry Nadler (D., N.Y.)reintroducedthe legislation.</p>\n<p>The senators are asking for input on the proposal by Sept. 1, so they can consider feedback before crafting the final bill. The proposal faces a difficult vote in the evenly-divided Senate.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-14 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cannabis&nbsp;stocks&nbsp;gains&nbsp;in premarket&nbsp;trading,as&nbsp;senators unveiling plan to end federal prohibition of cannabis.</p>\n<p>SNDL&nbsp;shares&nbsp;rises&nbsp;4%&nbsp;in&nbsp;premarket,&nbsp;TLRY&nbsp;and&nbsp;ACB&nbsp;shares&nbsp;are&nbsp;up&nbsp;2%.</p>\n<p><img src=\"https://static.tigerbbs.com/231cd44d5edcf10717dd42ede4ccbed1\" tg-width=\"1289\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>Senate Majority Leader Chuck Schumer (D., N.Y.), Sen. Ron Wyden (D., Oreg.) and Sen. Cory Booker (D., N.J.) are unveiling a discussion draft of their legislation to end the federal prohibition of marijuana. The senators will detail their plan at a press conference on July 14.</p>\n<p>The proposal— known as the Cannabis Administration and Opportunity Act — calls for removing cannabis from the federal list of controlled substances, allowing states to make their own decisions on cannabis. Many states have already moved to legalize recreational or medicinal marijuana use, but it still remains illegal under federal law.</p>\n<p>\"By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal,\" reads the discussion draft. \"State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled.\"</p>\n<p>The proposal establishes 21 as the minimum age to purchase cannabis and limits retail sales to no more than 10 ounces of cannabis. It calls for federal agencies to research the impacts of cannabis use, legalization and cannabis-impaired driving — including research to establish an impairment standard for driving under the influence of cannabis.</p>\n<p>The Democratic trio has been working on the legislation for months. In an interview withYahoo Financeshortly after they announced their plan to work on the proposal, Sen. Wyden said Congress should \"finally recognize that the War on Drugs has failed.\"</p>\n<p>The plan would require expungement of federal non-violent cannabis convictions and encourage state and local governments to do the same. It would keep people from being denied federal benefits — such as housing or federal financial aid — because of cannabis use or possession. People who are not U.S. citizens could not be denied benefits or protection under immigration laws.</p>\n<p>The plan would also create new grant programs to fund nonprofits that help people who have been \"adversely impacted by the War on Drugs.\" It would make loans available to small businesses in the cannabis industry and help states and localities implement cannabis licensing programs.</p>\n<p>President Joe Biden backed decriminalization of marijuana on the campaign trail, but the White House has not backed legalization efforts. In December, the Housepassed the MORE Act— which would remove marijuana from the controlled substance list and create restorative justice programs. Earlier this year, Rep. Jerry Nadler (D., N.Y.)reintroducedthe legislation.</p>\n<p>The senators are asking for input on the proposal by Sept. 1, so they can consider feedback before crafting the final bill. The proposal faces a difficult vote in the evenly-divided Senate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc.","SNDL":"SNDL Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165083410","content_text":"Cannabis stocks gains in premarket trading,as senators unveiling plan to end federal prohibition of cannabis.\nSNDL shares rises 4% in premarket, TLRY and ACB shares are up 2%.\n\nSenate Majority Leader Chuck Schumer (D., N.Y.), Sen. Ron Wyden (D., Oreg.) and Sen. Cory Booker (D., N.J.) are unveiling a discussion draft of their legislation to end the federal prohibition of marijuana. The senators will detail their plan at a press conference on July 14.\nThe proposal— known as the Cannabis Administration and Opportunity Act — calls for removing cannabis from the federal list of controlled substances, allowing states to make their own decisions on cannabis. Many states have already moved to legalize recreational or medicinal marijuana use, but it still remains illegal under federal law.\n\"By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal,\" reads the discussion draft. \"State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled.\"\nThe proposal establishes 21 as the minimum age to purchase cannabis and limits retail sales to no more than 10 ounces of cannabis. It calls for federal agencies to research the impacts of cannabis use, legalization and cannabis-impaired driving — including research to establish an impairment standard for driving under the influence of cannabis.\nThe Democratic trio has been working on the legislation for months. In an interview withYahoo Financeshortly after they announced their plan to work on the proposal, Sen. Wyden said Congress should \"finally recognize that the War on Drugs has failed.\"\nThe plan would require expungement of federal non-violent cannabis convictions and encourage state and local governments to do the same. It would keep people from being denied federal benefits — such as housing or federal financial aid — because of cannabis use or possession. People who are not U.S. citizens could not be denied benefits or protection under immigration laws.\nThe plan would also create new grant programs to fund nonprofits that help people who have been \"adversely impacted by the War on Drugs.\" It would make loans available to small businesses in the cannabis industry and help states and localities implement cannabis licensing programs.\nPresident Joe Biden backed decriminalization of marijuana on the campaign trail, but the White House has not backed legalization efforts. In December, the Housepassed the MORE Act— which would remove marijuana from the controlled substance list and create restorative justice programs. Earlier this year, Rep. Jerry Nadler (D., N.Y.)reintroducedthe legislation.\nThe senators are asking for input on the proposal by Sept. 1, so they can consider feedback before crafting the final bill. The proposal faces a difficult vote in the evenly-divided Senate.","news_type":1},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187992055,"gmtCreate":1623733505577,"gmtModify":1631890836843,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Do you agree? Leave a comment&nbsp;","listText":"Do you agree? Leave a comment&nbsp;","text":"Do you agree? Leave a comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/187992055","repostId":"2143178756","repostType":4,"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":851411293,"gmtCreate":1634920284934,"gmtModify":1634920285058,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"At the current price of $100 is it still good to enter?&nbsp;<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>","listText":"At the current price of $100 is it still good to enter?&nbsp;<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>","text":"At the current price of $100 is it still good to enter? $Digital World Acquisition Corp(DWAC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/851411293","isVote":1,"tweetType":1,"viewCount":2546,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":183898647,"gmtCreate":1623319331189,"gmtModify":1634034630929,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/183898647","repostId":"1127298356","repostType":4,"repost":{"id":"1127298356","kind":"news","pubTimestamp":1623310533,"share":"https://www.laohu8.com/m/news/1127298356?lang=&edition=full","pubTime":"2021-06-10 15:35","market":"us","language":"en","title":"Goldman Explains Why The Economy Won't Overheat, No Matter What Today's CPI Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=1127298356","media":"zerohedge","summary":"Yields on 10-year Treasuries dipped below 1.50% today for the first time since early March amid a fu","content":"<p>Yields on 10-year Treasuries dipped below 1.50% today for the first time since early March amid a furious shortsqueeze discussed earlier...</p>\n<p><img src=\"https://static.tigerbbs.com/e87da5d75100fe75f0be86933791246f\" tg-width=\"500\" tg-height=\"422\" referrerpolicy=\"no-referrer\">... and as post-pandemic inflation concerns appear to be waning as quickly as they flared up.</p>\n<p>This is a point we first brought up last month when observing the collapse in China's credit impulse, arguably the most important variable for the entire global reflationary narrative (see \"China's Credit Impulse Just Turned Negative, Unleashing Global Deflationary Shockwave\")...</p>\n<p><img src=\"https://static.tigerbbs.com/cfc3b4fc471bcf50ee51b9be637a3ed4\" tg-width=\"500\" tg-height=\"294\" referrerpolicy=\"no-referrer\">... and it's a point that Goldman's chief economist Jan Hatzius reiterated in a note published on Tuesday titled simply \"Why the Economy Won’t Overheat,” in which he argues - the same as the Fed - that the inflation we are seeing so far is likely to be temporary and prices will normalize again as we leg further away from unprecedented pandemic activity curtailments.</p>\n<p>While we disagree - and so does Deutsche Bank,which sees nothing short of Weimar hyperinflationbeing unleashed by the Fed soon, something we first predicted in March 2009 as the ultimate endgame -&nbsp; it is interesting that today, at least, markets appear to be adopting this view judging by the collapse in 10Y nominal rates and the recent breach of the upward trendline in breakevens...</p>\n<p><img src=\"https://static.tigerbbs.com/ef6de63c2434121178b1a7b351df6ee9\" tg-width=\"500\" tg-height=\"308\" referrerpolicy=\"no-referrer\">... this even as China's PPI printed at a Lehman Sept 2008 high of 9.0% overnight.</p>\n<p>So what, according to Goldman is the reason for receding inflation fears? As Hatzius and strategist Chris Hussey explain, the past 2 payrolls reports have been underwhelming as the rush back to work \"is being slowed by generous stimulus as well as an inability — perhaps — to simply process so many new workers. On the one hand, fewer available workers should push up wages as companies compete to attract new workers. But a more orderly stream of employment in the post-pandemic recovery may also allow for a more extended reopening period and perhaps a bit less top-line pressure on prices.\"</p>\n<p>Another reason for receding inflation fears may also simply be time. According to Goldman, as Americans become more accustomed to getting back to their daily routines, the strangeness of such activity recedes. And it is perhaps easier for investors to envision what‘normal’ will look like.&nbsp; And perhaps that vision is collectively coalescing around a‘new normal’ that looks surprisingly similiar to the pre-pandemic ‘old normal’.</p>\n<p>Hatzius then elaborates why the recent inflation pickup will remain transitory: \"On the wage side,<b>labor supply should increase dramatically over the next 3-6 months as fear of the virus diminishes further and the $300/week benefit top-up expires—over the next few weeks in most Republican-controlled states and on September 6 in the remaining states.\"</b></p>\n<p>In other words, employers will likely hold out another 3 months until the end of emergency benefits expire at which point they expect a flood of workers to reverse the calculus in the labor market,<b>from one of no labor supply to a flood of supply.</b></p>\n<p>On the price side, Goldman's trimmed core PCE—which excludes the 30% most extreme month-to-month price changes, and as a reminder the surge in inflation last month was largely driven by soaring used car prices and transportation services, or as Goldman puts it \"outliers\" — remains at just 1.56% year-on-year, half the standard core PCE rate.&nbsp; This gap illustrates the unprecedented role of outliers in the recent inflation pickup.</p>\n<p><img src=\"https://static.tigerbbs.com/3eaf58fed43ba69dc0224a4d192f457b\" tg-width=\"500\" tg-height=\"307\" referrerpolicy=\"no-referrer\">Ultimately, to Goldman, the biggest question in the overheating debate remains whether US output and employment will rise sharply above potential in the next few years. If the answer is yes, then inflation could indeed climb to undesirable levels on a more permanent basis. Predictably, Goldman's answer continues to be no, and here's why: \"Even though real GDP is nearly back to the pre-pandemic level, we still see significant slack in the economy based on the remaining jobs shortfall of nearly 8 million and the pandemic-driven productivity gain of 4.1% year-on-year in Q1. Moreover, we think sequential GDP growth has probably already peaked in monthly terms and will trend down from here as the fiscal impulse wanes, modestly at first and then more sharply in late 2021 and 2022.\"</p>\n<p><img src=\"https://static.tigerbbs.com/5bbda3c1cc274419a5ecdfeea29dd30b\" tg-width=\"500\" tg-height=\"324\" referrerpolicy=\"no-referrer\">Here JPMorgan also chimes in and in a recent note from economist Dan Silver writes that as we prepare for the CPI print, it is worthwhile to consider the impacts of the removal of federal unemployment benefits and increasing hourly wages. In Silver's note, he illustrates the growth in job openings among low-income jobs.</p>\n<p>JPM then asks the right question: \"<b>will wage increases remain durable if business owners know that supply is coming back online?\"</b>A question we have asked previously, and the answer is a decisive not. To JPM, if the answer is indeed no, \"we see a quicker than expected deceleration in wage growth, spending, and CPI.\" Although, alternatively, it seems more likely that we will also see a surge in jobs taken and potentially another leg higher in absolute macro data.</p>\n<p><img src=\"https://static.tigerbbs.com/dd33a3897ee720aefc640dc061344a18\" tg-width=\"500\" tg-height=\"332\" referrerpolicy=\"no-referrer\">With that in mind, what's next on the inflation catalyst front and what will today's critical CPI print show?&nbsp; Here, Goldman estimates a 0.50% increase in May core CPI (in line with consensus), which will boost the year-on-year rate by six tenths to 3.55%, up from 3.0% which however is largely impacted by the base effect collapse of last year. Goldman's monthly core inflation forecast<b>\"reflects reopening-driven strength in airfares, hotel prices, and recreation prices.\"</b>Additionally, Goldman expects strong monthly readings in used cars (+6%) and new cars (+0.5%), reflecting \"one-time\" supply chain disruptions and microchip shortages.</p>\n<p>And while the Fed is more concerned with PCE inflation rather than CPI, Goldman concludes that even though the inflation burst is transitory, \"<b>it will be interesting to see how markets react to a 3.5%+ inflation report in a monetary regime that presumably is focused on keeping inflation around 2%.\"</b></p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Explains Why The Economy Won't Overheat, No Matter What Today's CPI Shows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Explains Why The Economy Won't Overheat, No Matter What Today's CPI Shows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 15:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/goldman-explains-why-economy-wont-overheat-no-matter-what-tomorrows-cpi-shows?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Yields on 10-year Treasuries dipped below 1.50% today for the first time since early March amid a furious shortsqueeze discussed earlier...\n... and as post-pandemic inflation concerns appear to be ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/goldman-explains-why-economy-wont-overheat-no-matter-what-tomorrows-cpi-shows?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.zerohedge.com/markets/goldman-explains-why-economy-wont-overheat-no-matter-what-tomorrows-cpi-shows?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127298356","content_text":"Yields on 10-year Treasuries dipped below 1.50% today for the first time since early March amid a furious shortsqueeze discussed earlier...\n... and as post-pandemic inflation concerns appear to be waning as quickly as they flared up.\nThis is a point we first brought up last month when observing the collapse in China's credit impulse, arguably the most important variable for the entire global reflationary narrative (see \"China's Credit Impulse Just Turned Negative, Unleashing Global Deflationary Shockwave\")...\n... and it's a point that Goldman's chief economist Jan Hatzius reiterated in a note published on Tuesday titled simply \"Why the Economy Won’t Overheat,” in which he argues - the same as the Fed - that the inflation we are seeing so far is likely to be temporary and prices will normalize again as we leg further away from unprecedented pandemic activity curtailments.\nWhile we disagree - and so does Deutsche Bank,which sees nothing short of Weimar hyperinflationbeing unleashed by the Fed soon, something we first predicted in March 2009 as the ultimate endgame -  it is interesting that today, at least, markets appear to be adopting this view judging by the collapse in 10Y nominal rates and the recent breach of the upward trendline in breakevens...\n... this even as China's PPI printed at a Lehman Sept 2008 high of 9.0% overnight.\nSo what, according to Goldman is the reason for receding inflation fears? As Hatzius and strategist Chris Hussey explain, the past 2 payrolls reports have been underwhelming as the rush back to work \"is being slowed by generous stimulus as well as an inability — perhaps — to simply process so many new workers. On the one hand, fewer available workers should push up wages as companies compete to attract new workers. But a more orderly stream of employment in the post-pandemic recovery may also allow for a more extended reopening period and perhaps a bit less top-line pressure on prices.\"\nAnother reason for receding inflation fears may also simply be time. According to Goldman, as Americans become more accustomed to getting back to their daily routines, the strangeness of such activity recedes. And it is perhaps easier for investors to envision what‘normal’ will look like.  And perhaps that vision is collectively coalescing around a‘new normal’ that looks surprisingly similiar to the pre-pandemic ‘old normal’.\nHatzius then elaborates why the recent inflation pickup will remain transitory: \"On the wage side,labor supply should increase dramatically over the next 3-6 months as fear of the virus diminishes further and the $300/week benefit top-up expires—over the next few weeks in most Republican-controlled states and on September 6 in the remaining states.\"\nIn other words, employers will likely hold out another 3 months until the end of emergency benefits expire at which point they expect a flood of workers to reverse the calculus in the labor market,from one of no labor supply to a flood of supply.\nOn the price side, Goldman's trimmed core PCE—which excludes the 30% most extreme month-to-month price changes, and as a reminder the surge in inflation last month was largely driven by soaring used car prices and transportation services, or as Goldman puts it \"outliers\" — remains at just 1.56% year-on-year, half the standard core PCE rate.  This gap illustrates the unprecedented role of outliers in the recent inflation pickup.\nUltimately, to Goldman, the biggest question in the overheating debate remains whether US output and employment will rise sharply above potential in the next few years. If the answer is yes, then inflation could indeed climb to undesirable levels on a more permanent basis. Predictably, Goldman's answer continues to be no, and here's why: \"Even though real GDP is nearly back to the pre-pandemic level, we still see significant slack in the economy based on the remaining jobs shortfall of nearly 8 million and the pandemic-driven productivity gain of 4.1% year-on-year in Q1. Moreover, we think sequential GDP growth has probably already peaked in monthly terms and will trend down from here as the fiscal impulse wanes, modestly at first and then more sharply in late 2021 and 2022.\"\nHere JPMorgan also chimes in and in a recent note from economist Dan Silver writes that as we prepare for the CPI print, it is worthwhile to consider the impacts of the removal of federal unemployment benefits and increasing hourly wages. In Silver's note, he illustrates the growth in job openings among low-income jobs.\nJPM then asks the right question: \"will wage increases remain durable if business owners know that supply is coming back online?\"A question we have asked previously, and the answer is a decisive not. To JPM, if the answer is indeed no, \"we see a quicker than expected deceleration in wage growth, spending, and CPI.\" Although, alternatively, it seems more likely that we will also see a surge in jobs taken and potentially another leg higher in absolute macro data.\nWith that in mind, what's next on the inflation catalyst front and what will today's critical CPI print show?  Here, Goldman estimates a 0.50% increase in May core CPI (in line with consensus), which will boost the year-on-year rate by six tenths to 3.55%, up from 3.0% which however is largely impacted by the base effect collapse of last year. Goldman's monthly core inflation forecast\"reflects reopening-driven strength in airfares, hotel prices, and recreation prices.\"Additionally, Goldman expects strong monthly readings in used cars (+6%) and new cars (+0.5%), reflecting \"one-time\" supply chain disruptions and microchip shortages.\nAnd while the Fed is more concerned with PCE inflation rather than CPI, Goldman concludes that even though the inflation burst is transitory, \"it will be interesting to see how markets react to a 3.5%+ inflation report in a monetary regime that presumably is focused on keeping inflation around 2%.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":855989602,"gmtCreate":1635324421107,"gmtModify":1635324421107,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"It’s a good time to buy&nbsp;","listText":"It’s a good time to buy&nbsp;","text":"It’s a good time to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855989602","repostId":"1105918886","repostType":4,"repost":{"id":"1105918886","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635322218,"share":"https://www.laohu8.com/m/news/1105918886?lang=&edition=full","pubTime":"2021-10-27 16:10","market":"us","language":"en","title":"Trump stocks fell sharply in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1105918886","media":"Tiger Newspress","summary":"Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%","content":"<p>Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%.<img src=\"https://static.tigerbbs.com/a94b366462004373a3f94a989d88dc52\" tg-width=\"285\" tg-height=\"124\" referrerpolicy=\"no-referrer\">Donald Trump has dropped from the Forbes 400 list of the richest Americans for the first time in 25 years, according to the Forbes list. Although Trump's current value of $2.5 billion is still worthy of being called \"super rich\", he is still $400 million short of the Forbes 400 Rich List in the past.</p>\n<p>Last week,Trump announced plans to set up his new social platform \"TRUTH Social\" and go public through SPAC company DWAC.&nbsp;While&nbsp;Phunware's software previously provided mobile applications for Trump campaign team.And recently,Creatd&nbsp;announced a new non-fungible token art drop through its OG Gallery unit consisting of three photographs of Trump. The NFT includes three candid images of a young Donald Trump, captured as he signs the breast of a model.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trump stocks fell sharply in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrump stocks fell sharply in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-27 16:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%.<img src=\"https://static.tigerbbs.com/a94b366462004373a3f94a989d88dc52\" tg-width=\"285\" tg-height=\"124\" referrerpolicy=\"no-referrer\">Donald Trump has dropped from the Forbes 400 list of the richest Americans for the first time in 25 years, according to the Forbes list. Although Trump's current value of $2.5 billion is still worthy of being called \"super rich\", he is still $400 million short of the Forbes 400 Rich List in the past.</p>\n<p>Last week,Trump announced plans to set up his new social platform \"TRUTH Social\" and go public through SPAC company DWAC.&nbsp;While&nbsp;Phunware's software previously provided mobile applications for Trump campaign team.And recently,Creatd&nbsp;announced a new non-fungible token art drop through its OG Gallery unit consisting of three photographs of Trump. The NFT includes three candid images of a young Donald Trump, captured as he signs the breast of a model.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRTD":"Creatd Inc","PHUN":"Phunware, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105918886","content_text":"Trump stocks fell sharply in premarket trading,Phunware slid nearly 10%,Creatd and DWAC slid over 6%.Donald Trump has dropped from the Forbes 400 list of the richest Americans for the first time in 25 years, according to the Forbes list. Although Trump's current value of $2.5 billion is still worthy of being called \"super rich\", he is still $400 million short of the Forbes 400 Rich List in the past.\nLast week,Trump announced plans to set up his new social platform \"TRUTH Social\" and go public through SPAC company DWAC. While Phunware's software previously provided mobile applications for Trump campaign team.And recently,Creatd announced a new non-fungible token art drop through its OG Gallery unit consisting of three photographs of Trump. The NFT includes three candid images of a young Donald Trump, captured as he signs the breast of a model.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1023,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690703919,"gmtCreate":1639705922440,"gmtModify":1639705922561,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"😭","listText":"😭","text":"😭","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690703919","repostId":"2192920942","repostType":4,"isVote":1,"tweetType":1,"viewCount":1151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856999794,"gmtCreate":1635137360263,"gmtModify":1635137360978,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Climb&nbsp;","listText":"Climb&nbsp;","text":"Climb","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856999794","repostId":"1163651002","repostType":4,"isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":180309965,"gmtCreate":1623175000657,"gmtModify":1634036146504,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Is it worth a buy?","listText":"Is it worth a buy?","text":"Is it worth a buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/180309965","repostId":"1150047118","repostType":4,"repost":{"id":"1150047118","kind":"news","pubTimestamp":1623166569,"share":"https://www.laohu8.com/m/news/1150047118?lang=&edition=full","pubTime":"2021-06-08 23:36","market":"us","language":"en","title":"Zhangmen Education opens for trading at $17.74, up about 54% from IPO price","url":"https://stock-news.laohu8.com/highlight/detail?id=1150047118","media":"MarketWatch","summary":"(June 8) Zhangmen Education opens for trading at $17.74, up about 54% from IPO price.Zhangmen Educat","content":"<p>(June 8)&nbsp;Zhangmen Education opens for trading at $17.74, up about 54% from IPO price.</p><p><img src=\"https://static.tigerbbs.com/2ca3205e02c5697cdb0d18b2dd329fd9\" tg-width=\"750\" tg-height=\"514\"></p><p>Zhangmen Education Inc.ZME,&nbsp;is set to go public Tuesday, as the China-based online education company's initial public offering priced overnight to value the company at about $1.8 billion.</p><p>The IPO priced at $11.50 per American depositary share (ADS), within the expected pricing range of between $11 and $13 per ADS. The company sold 3.62 million ADS in the IPO to raise $41.7 million. Each ADS represented nine ordinary shares, and the company has a total of 1.42 billion ordinary shares outstanding, including 1.22 billion Class A ordinary shares.</p><p>The stock is expected to begin trading on the NYSE under the ticker symbol \"ZME.\"</p><p>Morgan Stanley and Credit Suisse were the joint book-running managers. The company recorded a net loss of RMB1.01 billion ($154.5 million) on revenue of RMB4.02 billion ($613.3 million) in 2020, after a loss of RMB1.50 billion on revenue of RMB2.67 billion in 2019.</p><p>The company is going public at a time that the Renaissance IPO ETFIPO,+1.90%has gained 5.4% over the past three months, iShares MSCI China ETFMCHI,-0.89%has edged up 0.8% and the S&amp;P 500SPX,-0.08%has advanced 10.6%.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhangmen Education opens for trading at $17.74, up about 54% from IPO price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhangmen Education opens for trading at $17.74, up about 54% from IPO price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 23:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/zhangmen-education-ipo-prices-valuing-the-company-at-about-18-billion-2021-06-08?siteid=rss&utm_campaign=Feed%3A+marketwatch%2Fmarketpulse+%28MarketWatch.com+-+MarketPulse%29&utm_medium=feed&utm_source=feedburner><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(June 8) Zhangmen Education opens for trading at $17.74, up about 54% from IPO price.Zhangmen Education Inc.ZME, is set to go public Tuesday, as the China-based online education company's initial ...</p>\n\n<a href=\"https://www.marketwatch.com/story/zhangmen-education-ipo-prices-valuing-the-company-at-about-18-billion-2021-06-08?siteid=rss&utm_campaign=Feed%3A+marketwatch%2Fmarketpulse+%28MarketWatch.com+-+MarketPulse%29&utm_medium=feed&utm_source=feedburner\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZME":"掌门教育"},"source_url":"https://www.marketwatch.com/story/zhangmen-education-ipo-prices-valuing-the-company-at-about-18-billion-2021-06-08?siteid=rss&utm_campaign=Feed%3A+marketwatch%2Fmarketpulse+%28MarketWatch.com+-+MarketPulse%29&utm_medium=feed&utm_source=feedburner","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1150047118","content_text":"(June 8) Zhangmen Education opens for trading at $17.74, up about 54% from IPO price.Zhangmen Education Inc.ZME, is set to go public Tuesday, as the China-based online education company's initial public offering priced overnight to value the company at about $1.8 billion.The IPO priced at $11.50 per American depositary share (ADS), within the expected pricing range of between $11 and $13 per ADS. The company sold 3.62 million ADS in the IPO to raise $41.7 million. Each ADS represented nine ordinary shares, and the company has a total of 1.42 billion ordinary shares outstanding, including 1.22 billion Class A ordinary shares.The stock is expected to begin trading on the NYSE under the ticker symbol \"ZME.\"Morgan Stanley and Credit Suisse were the joint book-running managers. The company recorded a net loss of RMB1.01 billion ($154.5 million) on revenue of RMB4.02 billion ($613.3 million) in 2020, after a loss of RMB1.50 billion on revenue of RMB2.67 billion in 2019.The company is going public at a time that the Renaissance IPO ETFIPO,+1.90%has gained 5.4% over the past three months, iShares MSCI China ETFMCHI,-0.89%has edged up 0.8% and the S&P 500SPX,-0.08%has advanced 10.6%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":849799713,"gmtCreate":1635776203533,"gmtModify":1635776203533,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>What’s happening&nbsp;","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>What’s happening&nbsp;","text":"$Naked Brand(NAKD)$What’s happening","images":[{"img":"https://static.tigerbbs.com/a9221a997ccd4e8a44354ac7a05795c6","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849799713","isVote":1,"tweetType":1,"viewCount":1223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":852236859,"gmtCreate":1635270147306,"gmtModify":1635270147484,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>Time to enter while at low!&nbsp;","listText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>Time to enter while at low!&nbsp;","text":"$Digital World Acquisition Corp(DWAC)$Time to enter while at low!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852236859","isVote":1,"tweetType":1,"viewCount":411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851413255,"gmtCreate":1634920191805,"gmtModify":1634920191971,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>how much will it close tonight?","listText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>how much will it close tonight?","text":"$Phunware, Inc.(PHUN)$how much will it close tonight?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851413255","isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851165572,"gmtCreate":1634882913211,"gmtModify":1634882913259,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"I should have bought&nbsp;","listText":"I should have bought&nbsp;","text":"I should have bought","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851165572","repostId":"1189311420","repostType":2,"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":117208291,"gmtCreate":1623141272913,"gmtModify":1634036512685,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/117208291","repostId":"1104815713","repostType":4,"repost":{"id":"1104815713","kind":"news","pubTimestamp":1623122553,"share":"https://www.laohu8.com/m/news/1104815713?lang=&edition=full","pubTime":"2021-06-08 11:22","market":"us","language":"en","title":"The Big Changes Coming to Your iPhone, iPad and Mac This Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=1104815713","media":"wsj","summary":"Apple is hosting its annualWorldwide Developers Conferencevirtually for the second year in a row. I ","content":"<p>Apple is hosting its annualWorldwide Developers Conferencevirtually for the second year in a row. I tuned in from home for the Monday keynote, where company execs outlined a slew of new updates for Apple devices due this fall via iOS 15, iPadOS 15, WatchOS 8 and MacOS Monterey.</p><p>The most exciting announcements are aimed directly at improving our experiences at home, where much of our work and play will continue even after the pandemic. FaceTime will get Zoom-like talents, plus the ability to share videos and music with other video-chat participants. And there are more iOS and watch features designed to increase focus and reduce stress.</p><p>The event is where Apple historically has expandedits walled garden, by announcing capabilities that will keep customers within its tightly locked hardware-software ecosystem. Sure enough, to get the most out of the newest Mac features, you will need an iPad, an iPhone and maybe even a second Mac. However, the company countered that narrative with a few other announcements: FaceTime now works in web browsers, so you can start up a video chat with people on Windows and Android devices, too. And Siri can be spoken to via other manufacturers’ HomeKit devices (though you will still need to own a HomePod).</p><p>In any case, the event is a reminder that Apple’s garden can be a pretty nice one. Many changes, available by way of a free software update in the fall, ought to add functionality to aging devices, including the six-year-old iPhone 6S. Some, of course, are reserved for only the newest Apple products. Here’s a breakdown of the most interesting announcements.</p><p><b>Chat and Productivity</b></p><p>FaceTime, Apple’s video chat app, is getting features already popular in competitors: blurred backgrounds, grid view for group calls, background-noise reduction, screen sharing and meeting links. The new functionality is available on both iOS and Mac devices. And, for the first time, Android and Windows users can join a FaceTime call via a Chrome or Edge web browser.</p><p>When there are multiple people on screen, the audio will sound like it is coming from the direction of the person who is speaking on screen. That feature—along with the Portrait Mode blurred background—is available only on iOS devices with A12 Bionic chips or newer, and 2018 Macs or newer.</p><p>In addition to sharing what is on your screen in FaceTime, you also can watch a video or listen to audio together. For now, supported apps include Disney+, TikTok and Hulu. Notably missing: Netflix.</p><p>Content shared in Messages will now show up in relevant apps. For example, if someone texts you photos, the images will be grouped in a new “Shared With You” tab in your Photos app. But images the app detects as memes or screenshots will be left out.</p><p>On the iPad, you still can manage two apps at the same time using Split View and Slide Over (as well as the single-app Full Screen). But instead of having to remember how to make that happen, a new pop-up menu will let you quickly switch between the setups. And a bottom “Shelf” lets you move between different windows in supported apps such as Safari and Pages.</p><p>For those with both an iPad and Mac, you can use your Mac’s mouse, trackpad and keyboard to control what is on your iPad, and even drag and drop files between them.</p><p>Safari gets a new feature that might convert you from Chrome or another browser: Tab groups, which can be easily accessed from Safari on any of your devices, let you store clusters of related websites.</p><p>The most productivity-boosting feature may involve extending your Mac’s battery life. That’s right, “low power mode,” found in iPhones, will be available in MacOS Monterey.</p><p><b>Focus and Mindfulness</b></p><p>The Away message is back, in the Messages app. When you turn on Do Not Disturb, Messages contacts will be able to see you have gone dark in their in-app conversations with you.</p><p>Notifications are getting smarter. You will be able to set up different focus modes, such as “Personal” or “Work,” which allow notifications from specific sets of apps and people for a custom duration (or even location). When you turn on a focus mode on one device, it will apply to all your other compatible Apple devices, too. In theory, it is designed to limit distractions—but it will likely take some tinkering to ensure that urgent calls from VIPs still come through.</p><p>If you want to be less bogged down by notifications, you can set all non-time-sensitive pop-ups to be bundled into a daily delivery.</p><p><b>AirPod Pro Improvements</b></p><p>My personal favorite announcement from today? Find My AirPods is finally useful—as long as you have Apple’s pricier buds. If you have AirPods Pro or Max, you can soon ping your earbuds—even if they are closed in their case. (Previously, this only worked if the buds were out of their case.) A new separation alert will also send you a notification if you leave the ’Pods behind in an unfamiliar location.</p><p>Conversation Boost is a capability designed for people with mild hearing loss. It focuses the AirPods’ audio on the person talking in front of you, and has controls to further reduce ambient noise.</p><p>The headphones also can be located through the global Apple Find My network, and their surround-sound audio mode, called Spatial Audio, which was formerly only compatible with recent iPhones and iPads, also will be available on Macs with the M1 chip.</p><p><b>On-device artificial intelligence</b></p><p>On-device artificial intelligence has many benefits over systems that depend on cloud processing. It is faster and more secure since, for instance, your voice commands don’t have to travel to company servers to be interpreted.</p><p>In its keynote, Apple showed off some Siri requests, such as setting a timer or switching to dark mode, that can work without an internet connection. Systemwide translation of text in languages such as Mandarin, Spanish and French, and Live Text—which can recognize text and numbers in photos or even live via the camera—also work on the device. They do require devices with the A12 Bionic chip or a newer processor, however.</p><p><b>Family-Wide Health</b></p><p>The Health app is where you will find data such as daily steps, heart rate and sleep. The coming version will allow you to share that data with others in your family. The thinking is that you can monitor an aging parents’ stats, and let them know if you are concerned, for example, about an increase in resting heart rate.</p><p><b>More Privacy Protections</b></p><p>Built-in privacy features have long been a part of Apple devices. But, for the first time, the company is including new privacy capabilities as part of its paid iCloud storage plans—now called iCloud+. Private Relay will act like a virtual private network, or VPN, by encrypting all your website traffic. The user is assigned an anonymous IP address, and the address of the destination website is encrypted. Apple says it doesn’t even know which site you are visiting.</p><p>The company also announced features that don’t require a subscription. Your driver’s license can be encrypted and stored in the Wallet app. The Transportation Security Administration is even working on using the digital IDs for security screening. However, it will initially only be available for license holders in select U.S. states.</p><p>The new version of the Mail app will block invisible pixels that collect information when you open an email. And a new settings page, called the App Privacy Report, shows how frequently apps use data such as location, access to the device’s microphone or contacts. It also will provide potentially creepy extras, such as all of the third-party domains your apps interact with.</p><p>As usual, Apple has targeted this massive software drop for the fall, which we expect to mean the September/October time frame when new iPhones traditionally arrive. The company didn’t announce any new hardware Monday, and we aren’t expecting much until the fall, when these new features—especially the ones that only work with the latest and greatest Apple gear—will drive up the temptation to upgrade.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Big Changes Coming to Your iPhone, iPad and Mac This Fall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Big Changes Coming to Your iPhone, iPad and Mac This Fall\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 11:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/the-big-changes-coming-to-your-iphone-ipad-and-mac-this-fall-11623106699?mod=hp_lead_pos5><strong>wsj</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is hosting its annualWorldwide Developers Conferencevirtually for the second year in a row. I tuned in from home for the Monday keynote, where company execs outlined a slew of new updates for ...</p>\n\n<a href=\"https://www.wsj.com/articles/the-big-changes-coming-to-your-iphone-ipad-and-mac-this-fall-11623106699?mod=hp_lead_pos5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.wsj.com/articles/the-big-changes-coming-to-your-iphone-ipad-and-mac-this-fall-11623106699?mod=hp_lead_pos5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104815713","content_text":"Apple is hosting its annualWorldwide Developers Conferencevirtually for the second year in a row. I tuned in from home for the Monday keynote, where company execs outlined a slew of new updates for Apple devices due this fall via iOS 15, iPadOS 15, WatchOS 8 and MacOS Monterey.The most exciting announcements are aimed directly at improving our experiences at home, where much of our work and play will continue even after the pandemic. FaceTime will get Zoom-like talents, plus the ability to share videos and music with other video-chat participants. And there are more iOS and watch features designed to increase focus and reduce stress.The event is where Apple historically has expandedits walled garden, by announcing capabilities that will keep customers within its tightly locked hardware-software ecosystem. Sure enough, to get the most out of the newest Mac features, you will need an iPad, an iPhone and maybe even a second Mac. However, the company countered that narrative with a few other announcements: FaceTime now works in web browsers, so you can start up a video chat with people on Windows and Android devices, too. And Siri can be spoken to via other manufacturers’ HomeKit devices (though you will still need to own a HomePod).In any case, the event is a reminder that Apple’s garden can be a pretty nice one. Many changes, available by way of a free software update in the fall, ought to add functionality to aging devices, including the six-year-old iPhone 6S. Some, of course, are reserved for only the newest Apple products. Here’s a breakdown of the most interesting announcements.Chat and ProductivityFaceTime, Apple’s video chat app, is getting features already popular in competitors: blurred backgrounds, grid view for group calls, background-noise reduction, screen sharing and meeting links. The new functionality is available on both iOS and Mac devices. And, for the first time, Android and Windows users can join a FaceTime call via a Chrome or Edge web browser.When there are multiple people on screen, the audio will sound like it is coming from the direction of the person who is speaking on screen. That feature—along with the Portrait Mode blurred background—is available only on iOS devices with A12 Bionic chips or newer, and 2018 Macs or newer.In addition to sharing what is on your screen in FaceTime, you also can watch a video or listen to audio together. For now, supported apps include Disney+, TikTok and Hulu. Notably missing: Netflix.Content shared in Messages will now show up in relevant apps. For example, if someone texts you photos, the images will be grouped in a new “Shared With You” tab in your Photos app. But images the app detects as memes or screenshots will be left out.On the iPad, you still can manage two apps at the same time using Split View and Slide Over (as well as the single-app Full Screen). But instead of having to remember how to make that happen, a new pop-up menu will let you quickly switch between the setups. And a bottom “Shelf” lets you move between different windows in supported apps such as Safari and Pages.For those with both an iPad and Mac, you can use your Mac’s mouse, trackpad and keyboard to control what is on your iPad, and even drag and drop files between them.Safari gets a new feature that might convert you from Chrome or another browser: Tab groups, which can be easily accessed from Safari on any of your devices, let you store clusters of related websites.The most productivity-boosting feature may involve extending your Mac’s battery life. That’s right, “low power mode,” found in iPhones, will be available in MacOS Monterey.Focus and MindfulnessThe Away message is back, in the Messages app. When you turn on Do Not Disturb, Messages contacts will be able to see you have gone dark in their in-app conversations with you.Notifications are getting smarter. You will be able to set up different focus modes, such as “Personal” or “Work,” which allow notifications from specific sets of apps and people for a custom duration (or even location). When you turn on a focus mode on one device, it will apply to all your other compatible Apple devices, too. In theory, it is designed to limit distractions—but it will likely take some tinkering to ensure that urgent calls from VIPs still come through.If you want to be less bogged down by notifications, you can set all non-time-sensitive pop-ups to be bundled into a daily delivery.AirPod Pro ImprovementsMy personal favorite announcement from today? Find My AirPods is finally useful—as long as you have Apple’s pricier buds. If you have AirPods Pro or Max, you can soon ping your earbuds—even if they are closed in their case. (Previously, this only worked if the buds were out of their case.) A new separation alert will also send you a notification if you leave the ’Pods behind in an unfamiliar location.Conversation Boost is a capability designed for people with mild hearing loss. It focuses the AirPods’ audio on the person talking in front of you, and has controls to further reduce ambient noise.The headphones also can be located through the global Apple Find My network, and their surround-sound audio mode, called Spatial Audio, which was formerly only compatible with recent iPhones and iPads, also will be available on Macs with the M1 chip.On-device artificial intelligenceOn-device artificial intelligence has many benefits over systems that depend on cloud processing. It is faster and more secure since, for instance, your voice commands don’t have to travel to company servers to be interpreted.In its keynote, Apple showed off some Siri requests, such as setting a timer or switching to dark mode, that can work without an internet connection. Systemwide translation of text in languages such as Mandarin, Spanish and French, and Live Text—which can recognize text and numbers in photos or even live via the camera—also work on the device. They do require devices with the A12 Bionic chip or a newer processor, however.Family-Wide HealthThe Health app is where you will find data such as daily steps, heart rate and sleep. The coming version will allow you to share that data with others in your family. The thinking is that you can monitor an aging parents’ stats, and let them know if you are concerned, for example, about an increase in resting heart rate.More Privacy ProtectionsBuilt-in privacy features have long been a part of Apple devices. But, for the first time, the company is including new privacy capabilities as part of its paid iCloud storage plans—now called iCloud+. Private Relay will act like a virtual private network, or VPN, by encrypting all your website traffic. The user is assigned an anonymous IP address, and the address of the destination website is encrypted. Apple says it doesn’t even know which site you are visiting.The company also announced features that don’t require a subscription. Your driver’s license can be encrypted and stored in the Wallet app. The Transportation Security Administration is even working on using the digital IDs for security screening. However, it will initially only be available for license holders in select U.S. states.The new version of the Mail app will block invisible pixels that collect information when you open an email. And a new settings page, called the App Privacy Report, shows how frequently apps use data such as location, access to the device’s microphone or contacts. It also will provide potentially creepy extras, such as all of the third-party domains your apps interact with.As usual, Apple has targeted this massive software drop for the fall, which we expect to mean the September/October time frame when new iPhones traditionally arrive. The company didn’t announce any new hardware Monday, and we aren’t expecting much until the fall, when these new features—especially the ones that only work with the latest and greatest Apple gear—will drive up the temptation to upgrade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":690704308,"gmtCreate":1639706305167,"gmtModify":1639706953509,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690704308","repostId":"1172405131","repostType":4,"isVote":1,"tweetType":1,"viewCount":1373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":153240811,"gmtCreate":1625029631033,"gmtModify":1631890836808,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Got me thinking&nbsp;","listText":"Got me thinking&nbsp;","text":"Got me thinking","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/153240811","repostId":"2147585034","repostType":4,"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165335904,"gmtCreate":1624094264308,"gmtModify":1631890836837,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Hold clover stocks!&nbsp;","listText":"Hold clover stocks!&nbsp;","text":"Hold clover stocks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165335904","repostId":"1166679093","repostType":4,"repost":{"id":"1166679093","kind":"news","pubTimestamp":1624065234,"share":"https://www.laohu8.com/m/news/1166679093?lang=&edition=full","pubTime":"2021-06-19 09:13","market":"us","language":"en","title":"3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166679093","media":"fool","summary":"Meme stocks have been all the rage so far this year. That's understandable, with several of them del","content":"<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.</p>\n<p>However, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.</p>\n<p>AMC Entertainment</p>\n<p><b>AMC Entertainment</b>(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.</p>\n<p>The consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.</p>\n<p>But isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.</p>\n<p>However, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.</p>\n<p>Clover Health Investments</p>\n<p>Only a few days ago, it looked like&nbsp;<b>Clover Health Investments</b>(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.</p>\n<p>Since the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.</p>\n<p>Clover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.</p>\n<p>Still, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.</p>\n<p>Sundial Growers</p>\n<p>At one point earlier this year,&nbsp;<b>Sundial Growers</b>(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.</p>\n<p>Analysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.</p>\n<p>There certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.</p>\n<p>Sundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.</p>\n<p>However, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the&nbsp;<b>Nasdaq</b>&nbsp;stock exchange.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp","SNDL":"SNDL Inc.","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166679093","content_text":"Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.\nAMC Entertainment\nAMC Entertainment(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.\nThe consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.\nBut isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.\nHowever, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.\nClover Health Investments\nOnly a few days ago, it looked like Clover Health Investments(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.\nSince the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.\nClover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.\nStill, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.\nSundial Growers\nAt one point earlier this year, Sundial Growers(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.\nAnalysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.\nThere certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.\nSundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.\nHowever, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the Nasdaq stock exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117209462,"gmtCreate":1623141170956,"gmtModify":1634036515000,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Hopefully it will sustain in the Long run","listText":"Hopefully it will sustain in the Long run","text":"Hopefully it will sustain in the Long run","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/117209462","repostId":"1151090475","repostType":4,"repost":{"id":"1151090475","kind":"news","pubTimestamp":1623140703,"share":"https://www.laohu8.com/m/news/1151090475?lang=&edition=full","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":690797621,"gmtCreate":1639707049357,"gmtModify":1639708339012,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Oh my&nbsp;","listText":"Oh my&nbsp;","text":"Oh my","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690797621","repostId":"1155708308","repostType":2,"repost":{"id":"1155708308","kind":"news","pubTimestamp":1639706709,"share":"https://www.laohu8.com/m/news/1155708308?lang=&edition=full","pubTime":"2021-12-17 10:05","market":"us","language":"en","title":"BKKT Stock Alert: Why Is Bakkt Plunging","url":"https://stock-news.laohu8.com/highlight/detail?id=1155708308","media":"InvestorPlace","summary":"Digital asset manager Bakkt(NYSE:BKKT) is in freefall on Thursday after a recent Securities and Exch","content":"<p>Digital asset manager&nbsp;<b>Bakkt</b>(NYSE:<b><u>BKKT</u></b>) is in freefall&nbsp;on&nbsp;Thursday&nbsp;after a recent Securities and Exchange Commission (SEC) filing has investors spooked. BKKT stock is down big today, just two months after its October SPAC debut.</p>\n<p>So, what’s causing this slump in Bakkt?</p>\n<p>Bakkt is falling victim to an apparent PIPE (private investment in public equity) selloff. Yesterday, Bakkt filed an S-1 registration statement with the SEC,&nbsp;allowing early investors&nbsp;in the company freedom to sell their stake. Consequently, they did. Bakkt has already shed more than 31% of its share price as investors cool off on the once red-hot stock.</p>\n<p>Founded in 2018, Bakkt went public just this past October. A week after its debut, BKKT went as high as $42.52 per share amid sky-high investor interest. However, it seems the party is over. Accounting for today’s losses so far, Bakkt is trending a bit below $10 at the time of writing.</p>\n<p>What else do you need to know about Bakkt’s dive?</p>\n<p><b>BKKT Stock Flounders as Bears Come Out on Top</b></p>\n<p>While the PIPE unlocking is wreaking havoc on shareholder wallets, Bakkt is grasping at straws to put a stop to the decline.</p>\n<p>The Georgia-based company is best known for its digital asset exchange platform. Bakkt is the latest crypto exchange making waves after its app launched under the guidance of parent company Intercontinental Exchange.</p>\n<p>Unfortunately, since its Oct. 25 peak, it’s been a downhill story for the crypto exchange. Even despite a headline-grabbing&nbsp;integration announcement&nbsp;with&nbsp;<b>Alphabet’s</b>&nbsp;Google Pay, Bakkt can’t seem to reverse its fortune.</p>\n<p>Additionally, just this week Bakkt began offering&nbsp;<b>WyndhamRewards</b>&nbsp;members the ability to convert reward points into cash deposited directly into their accounts. Unfortunately, it was seemingly to no avail.</p>\n<p>Time will tell just how far BKKT will drop. However, for those looking for cheap crypto exposure, a rock-bottom entry point like this could be appealing.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BKKT Stock Alert: Why Is Bakkt Plunging</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBKKT Stock Alert: Why Is Bakkt Plunging\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 10:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/bkkt-stock-alert-why-is-bakkt-plunging-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Digital asset manager Bakkt(NYSE:BKKT) is in freefall on Thursday after a recent Securities and Exchange Commission (SEC) filing has investors spooked. BKKT stock is down big today, just two months ...</p>\n\n<a href=\"https://investorplace.com/2021/12/bkkt-stock-alert-why-is-bakkt-plunging-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BKKT":"Bakkt Holdings, Inc."},"source_url":"https://investorplace.com/2021/12/bkkt-stock-alert-why-is-bakkt-plunging-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155708308","content_text":"Digital asset manager Bakkt(NYSE:BKKT) is in freefall on Thursday after a recent Securities and Exchange Commission (SEC) filing has investors spooked. BKKT stock is down big today, just two months after its October SPAC debut.\nSo, what’s causing this slump in Bakkt?\nBakkt is falling victim to an apparent PIPE (private investment in public equity) selloff. Yesterday, Bakkt filed an S-1 registration statement with the SEC, allowing early investors in the company freedom to sell their stake. Consequently, they did. Bakkt has already shed more than 31% of its share price as investors cool off on the once red-hot stock.\nFounded in 2018, Bakkt went public just this past October. A week after its debut, BKKT went as high as $42.52 per share amid sky-high investor interest. However, it seems the party is over. Accounting for today’s losses so far, Bakkt is trending a bit below $10 at the time of writing.\nWhat else do you need to know about Bakkt’s dive?\nBKKT Stock Flounders as Bears Come Out on Top\nWhile the PIPE unlocking is wreaking havoc on shareholder wallets, Bakkt is grasping at straws to put a stop to the decline.\nThe Georgia-based company is best known for its digital asset exchange platform. Bakkt is the latest crypto exchange making waves after its app launched under the guidance of parent company Intercontinental Exchange.\nUnfortunately, since its Oct. 25 peak, it’s been a downhill story for the crypto exchange. Even despite a headline-grabbing integration announcement with Alphabet’s Google Pay, Bakkt can’t seem to reverse its fortune.\nAdditionally, just this week Bakkt began offering WyndhamRewards members the ability to convert reward points into cash deposited directly into their accounts. Unfortunately, it was seemingly to no avail.\nTime will tell just how far BKKT will drop. However, for those looking for cheap crypto exposure, a rock-bottom entry point like this could be appealing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846430950,"gmtCreate":1636102914954,"gmtModify":1636102915010,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576458191145383","authorIdStr":"3576458191145383"},"themes":[],"htmlText":"Oh my&nbsp;","listText":"Oh my&nbsp;","text":"Oh my","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846430950","repostId":"1194946622","repostType":4,"repost":{"id":"1194946622","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636101187,"share":"https://www.laohu8.com/m/news/1194946622?lang=&edition=full","pubTime":"2021-11-05 16:33","market":"us","language":"en","title":"Bionano Genomics stock tanked more than 8% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1194946622","media":"Tiger Newspress","summary":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $","content":"<p>Bionano Genomics stock tanked more than 8% in premarket trading&nbsp;after&nbsp;Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p>\n<p><img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p><b>Bionano Genomics, Inc.</b>&nbsp;reported financial results and business achievements for the quarter ended&nbsp;September&nbsp;30, 2021&nbsp;and highlighted recent corporate updates.</p>\n<p><i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p>\n<p><i>–&nbsp;Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p>\n<p><i>–&nbsp;Record number of Saphyr shipments and installations for any quarter to date</i></p>\n<p><i>–&nbsp;Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p>\n<p><i>–&nbsp;Remaining 2021 milestones on track</i></p>\n<p><i>–&nbsp;Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember&nbsp;30, 2021</i></p>\n<p>“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p>\n<p>Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p>\n<p><b>Key Business Highlights in Q3</b></p>\n<p>The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p>\n<p>–<b>&nbsp;Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p>\n<p>–<b>&nbsp;Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p>\n<p>–<b>&nbsp;Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p>\n<p>–&nbsp;<b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham &amp; Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p>\n<p>–<b>&nbsp;The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p>\n<p>–<b>&nbsp;NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p>\n<p>–<b>&nbsp;Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p>\n<p>–&nbsp;<b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p>\n<p>–&nbsp;<b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p>\n<p><b>Financial Highlights</b></p>\n<p>–<b>&nbsp;Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p>\n<p>–<b>&nbsp;Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p>\n<p>–<b>&nbsp;Third quarter operating expense was$21.8 million,</b>compared to$17.9&nbsp;million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p>\n<p>–&nbsp;<b>AtSeptember&nbsp;30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p>\n<p><b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p>\n<p>–&nbsp;4Q21: Interim publication of results from pediatric clinical study</p>\n<p>–&nbsp;4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p>\n<p>–&nbsp;4Q21: Initial prototype of next gen high throughput Saphyr</p>\n<p>–&nbsp;4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics stock tanked more than 8% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics stock tanked more than 8% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-05 16:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bionano Genomics stock tanked more than 8% in premarket trading&nbsp;after&nbsp;Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p>\n<p><img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p><b>Bionano Genomics, Inc.</b>&nbsp;reported financial results and business achievements for the quarter ended&nbsp;September&nbsp;30, 2021&nbsp;and highlighted recent corporate updates.</p>\n<p><i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p>\n<p><i>–&nbsp;Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p>\n<p><i>–&nbsp;Record number of Saphyr shipments and installations for any quarter to date</i></p>\n<p><i>–&nbsp;Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p>\n<p><i>–&nbsp;Remaining 2021 milestones on track</i></p>\n<p><i>–&nbsp;Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember&nbsp;30, 2021</i></p>\n<p>“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p>\n<p>Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p>\n<p><b>Key Business Highlights in Q3</b></p>\n<p>The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p>\n<p>–<b>&nbsp;Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p>\n<p>–<b>&nbsp;Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p>\n<p>–<b>&nbsp;Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p>\n<p>–&nbsp;<b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham &amp; Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p>\n<p>–<b>&nbsp;The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p>\n<p>–<b>&nbsp;NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p>\n<p>–<b>&nbsp;Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p>\n<p>–&nbsp;<b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p>\n<p>–&nbsp;<b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p>\n<p><b>Financial Highlights</b></p>\n<p>–<b>&nbsp;Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p>\n<p>–<b>&nbsp;Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p>\n<p>–<b>&nbsp;Third quarter operating expense was$21.8 million,</b>compared to$17.9&nbsp;million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p>\n<p>–&nbsp;<b>AtSeptember&nbsp;30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p>\n<p><b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p>\n<p>–&nbsp;4Q21: Interim publication of results from pediatric clinical study</p>\n<p>–&nbsp;4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p>\n<p>–&nbsp;4Q21: Initial prototype of next gen high throughput Saphyr</p>\n<p>–&nbsp;4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194946622","content_text":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.\n\nBionano Genomics, Inc. reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.\n– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics\n– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base\n– Record number of Saphyr shipments and installations for any quarter to date\n– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications\n– Remaining 2021 milestones on track\n– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021\n“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.\nChris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”\nKey Business Highlights in Q3\nThe Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:\n– Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.\n– Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.\n– Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applicationssupporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.\n– OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centersinthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.\n– The largest clinical research study to date evaluating OGM was published inThe Journal of Molecular Diagnosticsfor a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.\n– NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.\n– Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.\n– Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.\n– Added exceptional talent across commercial leadership functions,includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.\nFinancial Highlights\n– Total revenue for the third quarter of 2021 was$4.7 million,up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.\n– Gross margin for the third quarter of 2021 was 24.8%,compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.\n– Third quarter operating expense was$21.8 million,compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.\n– AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 millioncompared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.\nRemaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr\n– 4Q21: Interim publication of results from pediatric clinical study\n– 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study\n– 4Q21: Initial prototype of next gen high throughput Saphyr\n– 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020","news_type":1},"isVote":1,"tweetType":1,"viewCount":1250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}